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In metazoan cells the DNA replication origins are not well defined. Differently 
from what observed for bacteria cells and for budding yeast, in metazoan the origins 
does not show a conserved sequence and they appear to be specified by many factors. In 
order to better understand the mechanisms involved in the origin specification, many 
studies have been done to identify the proteins involved in the recognition and 
activation of the origins. From these kind of analysis is emerging that, beside the well-
known proteins of the pre replicative complex, also other factors might be involved. 
Between these, the HOX proteins seem to be able to play a role in the origin activity. 
One of the first studies of this involvement was done by our group and leads to the 
identification of three homeotic proteins able to specifically bind in vitro the human 
lamin B2 origin. Thus, in the study conducted during this PhD program, was 
investigated the involvement of one of these homeotic proteins, namely HOXC13, with 
human DNA replication origins and with replicative complexes.  
We found an interaction of HOXC13 with two crucial factors of the pre 
Replication Complex (pre-RC), ORC1 and Cdc6 and that HOXC13 binds a good 
fraction of the origins, in particular the early replicating ones, like the lamin B2 origin 
and other known human origins. The HOXC13 protein is bound to origin chromatin, at 
least for the lamin B2 origin, at a precise site within the pre-RC at specific moments of 
the cell cycle. Interaction with the origin occurs within the area protected by the pre-RC 
in G1, very close to the start sites of leading strand synthesis and to the binding sites of 
ORC1, ORC2, Cdc6, topoisomerase (topo) I and topo II. The protein is absent from the 
origin in M and appears on it at the beginning of G1, reach a peak at G1/S and as 
synthesis starts, the interaction of HOXC13 with the origin fades, in parallel with the 
transition from this large pre-RC to a smaller and differently organized post-RC. 
Recently also other HOX proteins have been identify as proteins involved in 
regulation processes of DNA replication, suggesting that the interaction of HOXC13 
with the origins might occur in a multi-homeotic proteins complex. Depletion of one of 
these proteins however is compatible with the continuation of the cell cycle and, 
according with what observed for the other homeotic proteins, we found that also the 
depletion of HOXC13 does not alter cell cycle progression or S phase entry. This is 
probably due to the redundancy of homeotic proteins and indicates a relatively generic 
function for the HOX proteins.  
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Among the identified elements influencing the choice and the activity of a 
sequence as DNA replication origin, much relevance is assumed by the chromatin 
structure and topology of DNA. Therefore, we analysed the effects of chromatin 
structure disruption using Tricostatin A, a histone deacetylase inhibitor. The alteration 
of chromatin caused by this treatment not only sharply reduces origin function, but also 
disturbs the binding of replication complex members like HOXC13 and the well known 
Cdc6 to the DNA replication origins, while does not affect the binding of other 
unrelated proteins like USF1. On the basis of this finding, we infer that an appropriate 
chromatin organization and DNA topology strongly influence the binding between 
factors of the pre Replication Complex and DNA replication origins. This influence 
could be a key element in origin specification. 
The described interactions are not restricted to a single origin nor to a single 
homeotic protein, leading us to conclude that HOX proteins, probably in the context of a 
multi-protein homeotic effectors, contribute to recruit and stabilize the replicative 
complexes onto early replicating origins, in presence of specific chromatin and 
topological configurations. 
The relevance of HOXC13 in DNA replication is also underlined by its 
involvement in oncogenesis, clearly demonstrated in acute myeloid leukaemia when 























































1.1. DNA replication  
 
1.1.1. Eukaryotic DNA replication  
 
Cells begin DNA replication from specifically selected chromosomal sites termed 
replication initiation sites or replication origins. The chromosomal DNA is subdivided 
into a number of tandemly organized replicons, ranging in number from ~400 in yeast 
to ~30,000 in humans. Each replicon contains a replication origin, a sequence that is the 
final target of specific proteins that lead to the recognition of the specific origin, 
unwinding of DNA, formation of replication forks and synthesis of new strands. The 
two opposite moving replication forks progress through the replication until they merge 
with those issued from the adjacent ones. In metazoans DNA replication is a tightly 
regulated process, ensuring that the genome is duplicated only once each cell cycle, 
before chromosome segregation and cytokinesis.  
The initial event in DNA replication is constituted by the origin selection 
mediated by the binding of the Origin Recognition Complex (ORC) into origin DNA 
sequences. The ORC complex provides a "landing-pad" for other proteins including 
Cdc6, Cdt1, DNA helicase complex Mcm2-7 and others. All together these proteins 
form the so called pre-Replication Complex (pre-RC) that is formed in G1 phase of the 
cell cycle and marks the potential sites for the initiation of DNA replication.  Each 
replication origin spaced apart from 50 to 250 kb, depending on the development stage, 
growth conditions and cell transformation status. 
 
 
1.1.2. The Replicon model 
 
The main principles characterizing the events that initiate the DNA replication are 
conserved in evolution and were described in replicon model, formulated in 1963 by 
Jacob and Brenner1. This model postulates the presence of specific cis-acting sequence 
elements, termed replicator, that genetically determine replication-initiation sites on 
DNA molecules. The replicators interact with trans-acting regulatory factors, termed 
initiators, able to recognize the replicators on the genome in response to appropriate 
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cellular signals (Figure1). The first event in the initiation of DNA synthesis is the 
chromatin decondensation and local opening of the duplex strands to provide the access 
for the initiators. 
The replicon model was proposed to explain the regulation of the Escherichia coli 
DNA replication and provided a foundation to understand how the initiation of DNA 
replication occurs in all organisms. With this model two new elements were introduced: 
the existence of specific site where the double helix of DNA is opened and the 
involvement of proteins other than polymerases in DNA replication.  
In bacteria the initiation of DNA replication at oriC requires origin binding by the 
initiator protein dnaA. This binding alters the structure of the origin and provides an 
associative platform for targeting additional proteins as dnaB, an helicase involved in 
the progression of the replication fork. DnaB also allows the loading of an other 
replication-fork enzyme called primase, which is a replication-priming RNA 
polymerase2. Together, the helicase and primase form the core of the so called 
"primosome"3. During the entire course of replication, the dnaB helicase catalyzes the 
unwinding of genomic DNA in an ATP dependent reaction4. This model was validated 
in numerous prokaryotic and viral systems. 
The unwinding of the double stranded genomic DNA is energetically unfavorable, 
thus the cells have evolved helicases enzymes, that couple the energy of NTP binding 
and hydrolysis to the unwinding5. Families of helicases share several sequences and 
structural motifs, implying that there is a common unwinding mechanism used by these 
enzymes. 
The first extension of this model from prokaryotes to eukaryotic chromosomes 
was the identification of Autonomously Replicating Sequences (ARS) in budding yeast. 
Analysis of the ARS revealed that these are about 100bp sequences and consist of a 
17bp consensus A-domain region with an 11bp ARS Consensus Sequences (ACS) that 
is AT rich and flanked by poorly conserved B domains. The A and the B1 domains are 
binding sites for the proteins involved in DNA replication, while others B elements act 
as enhancers for the origin efficiency. The identification of consensus ARS elements 
has permitted the isolation of the Origin Recognition Complex ORC, the protein 
complex that binds to the origin sequences and allows the DNA replication in all 
eukaryotes. 
Actually, in many eukaryotes the consensus sequence conservation at replicons 
may not be completely faithful because of the very little sequence specificity among 
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origins, differently from what observed in budding yeast. AT richness is generally 
retained feature and is assumed to be important for facilitate the opening of DNA 
strands at the origin. However, in the other eukaryotes as in fission yeast, the origins are 
generally longer, without any identifiable conserved consensus sequences analogous to 
ACS and in many cases, in contrast to the budding yeast, inefficient origins, that fire 
randomly, are spread in the genome6. Thus, S. cerevisiae appears to be an exception in 
the eukaryotes. The eukaryotic origins seem to be defined by different combinations of 
elements depending on the context that license them to be recognized by "initiators" 
including several features like DNA sequence, but there is not a single consensus 





















Figure 1. The replicon model. A trans-acting protein encoded by the initiator gene was proposed 





1.1.3. Replication complex 
 
The mechanism of initiation of eukaryotic replication is based on in the "origin 
licensing" model. In this model, origins are licensed once the pre Replication Complex 
(pre-RC)is entirely loaded onto them, and the ORC complex is the first to be involved in 
this assembly (Figure 2).  
The ORC complex consists of six subunits (ORC1-6) discovered by specific 
isolation of ACS binding proteins in budding yeast. These proteins are conserved in 
evolution but their DNA specific binding dependence, present in budding yeast, is lost 
in the other eukaryotes. In S. pombe, ORC-origin binding to origins is mediated 
uniquely by ORC4, which is able to recognize and bind specifically AT-rich sequences 
through its AT-hook DNA binding motif7. This feature of ORC4 is limited to S. pombe. 
The specificity of mammalian ORC binding to DNA is very low, due to its limited 
ability to distinguish specific sequences8. Moreover, the difficulties in identifying well-
defined ORC binding sites in species other than yeast raise the possibility that other 
DNA binding factors may contribute and facilitate ORC localization and origin 
selection. The human, frog and S. pombe ORCs preferentially bind DNA to AT rich 
tracts but there is not a clear consensus sequences among these regions. The AT regions 
are characterized by their helical instability that facilitates probably the DNA unwinding 
and their recognition as replication origins9, 10. Therefore, the chromatin structure, and 
not only the primary DNA sequence, might be the element recognized by ORC. 
The ORC subunits are AAA+ ATPases (ATPase Associated with various cellular 
Activities) but only the ATPase activity of ORC1 is required for DNA binding11. 
Contrary to yeast, in mammals some of the subunits of ORC complex are displaced 
from the origin site after initiation of DNA replication12, suggesting a more dynamic 
interaction between mammalian ORC and origin DNA. In human cells, the ORC1 
subunit in S-phase is selectively destabilized, ubiquitinated, partially degraded, and then 
stably bound to chromatin during the next M to G1 transition, to establish the pre-RC at 
specific genomic sites in G1 phase. Moreover, species-specific variations exist in the 
regulation of ORC activity, because although ORC proteins are highly conserved within 
a single taxonomic family, conservation among all species is modest13. 
The ORC1 ATPase is activated by the binding of Cdc6, an other AAA+ ATPase, 
that induced conformational changes on DNA that increase the specificity of the binding 
of ORC-Cdc6 complex to origins. Moreover, Cdc6 ATPase activity determine its 
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dissociation from ORC-Cdc6-DNA complex, in non origin sequences, while inhibition 
of Cdc6 ATPase on origin DNA sequences results in a stable ORC-Cdc6-DNA 
complex, which can then promote MCM loading to origins. Therefore, Cdc6 ATPase 
activity regulates origin DNA sequence specificity for the assembly of the pre-RC, 
required for DNA replication initiation. In fact, mutations increasing Cdc6 ATPase 
activity result in a less stable complex on DNA14. 
After the origin binding by ORC-Cdc6 proteins, the next step is the loading of  
Cdt1. Duringthe M to G1-transition, in human cells Cdc6 is degraded and then 
resynthesized later during G1-phase15. 
Cdt1 has been shown to be a key element in the formation of the pre-RC, in 
particular, regulating the “once per cell cycle” replication feature. Cdt1 is periodically 
expressed under the control of the transcription factor Cdc10, which also controls the 
expression of Cdc6 in different species16. 
Moreover, the Cdc6 ATPase activity is seem to be required for Cdt1 binding to 
the origin, perhaps determining the following loading of MCM complex onto the ORC-
Cdc6-DNA complex. Cdt1 activity is additionally regulated by differential 
stoichiometric binding of a DNA replication inhibitor, Geminin, and by proteolysis17.  
Geminin is a known as inhibitor of DNA replication that acts by preventing MCM 
loading onto origins throughout S and M phase and impeding unwanted additional 
firing events. This protein plays multiple roles in several fundamental cellular processes 
including proliferation, differentiation, development and transcriptional regulation. All 
these functions have been characterized by identifying Geminin binding partners18. 
Geminin was shown to interact with Cdt1 during the S phase, targeting it for 
degradation thereby preventing MCM loading until the following G1 phase and hence 
preventing re-replication19. The balances of the Geminin-Cdt1 association establishes 
the timing of DNA replication initiation and controls the cell cycle progression20. 
During S-G2/M phases, Geminin binds Cdt1 at increased stoichiometric ratios and 
suppress Cdt1 function. However, through pre-RC licensing, Geminin binds Cdt1 in a 
lower stoichoimetric ratio, allowing the presence of an active form of Cdt1 that can 
interact with Cdc6 and ORC21. The Cdt1-Geminin complex can exist in two distinct 
forms, as heterotrimer and as heterohexamer and the hexamer formation is critical for 
full inhibition of Cdt1 by Geminin. Probably the abbundance of heterotrimer and 
heteroexamer is regulated during the cell cycle22. The levels of Geminin rise during S 
phase and its degradation is mediated by the anaphase promoting complex (APC) in 
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mitosis or by a nonproteolytic inactivation of the fraction of Geminin that escaped from 
degradation. 
Localization of Cdt1 to the origin is essential for MCM complex recruitment. 
Then, Cdt1 and Cdc6 dissociate from the origin and ATP hydrolysis by ORC completes 
the MCM loading23. 
The MCM genes were first identified in mutants defective on the maintenance of 
mini-chromosomes in budding yeast (Mcm phenotype)24. A subset of these MCM 
mutations were found in a family of six paralogous genes numbered MCM from 2 to 7, 
which are highly conserved in eukaryotes. The MCM complex consist of six AAA+-
ATPase subunits MCM 2-7, structured in a ring-shaped conformation around the 
chromatin25. After the initial recruitment of MCM to the origin, Cdc6 ATPase activity 
allows the disassociation of Cdt1 from the pre-RC, an important step that allows the 
MCM ring to close around the DNA23. This ATPase activity is followed by the ORC 
ATPase activity that completes the MCM loading reaction and may promote further 
rounds of MCM loading. Thus, the cooperation between replisome loading and helicase 
activation ensures coordinated replication of the two strands of DNA.  
The assembly of pre-RC is not sufficient to initiate DNA replication, because the 
replication process requires the activation of two S-phase promoting kinases, CDKs 
(Cyclin-Dependent Kinases) and DDK (Dbf4-Dependent Kinase,Cdc7) during the G1/S 
transition. CDKs and DDK phosphorylate and activate pre-RCs promoting the loading 
of other factors like MCM10, Cdc45 and GINS, thereby forming the pre-IC (pre-
Initiation Complex) and triggering origin firing26, 27. The large multiprotein complex 
formed after the licensing is called pre-Initiation Complex (pre-IC), from which start 
two diverging semi-conservative replicative forks that progress in opposite directions 
until converge with the replicative forks coming from the adjacent origins.  
Phosphorylation of ORC, Cdc6, Cdt1 and MCM proteins also results in their 
inactivation and/or disassociation from the origin, nuclear export and proteasomal 
degradation; and finally establish post-RC (post-Replicative Complex), a state required 
to prevent origin re-licensing21,28-30. 
The CDK and DDK enzymes are independently regulated by similar mechanisms. 
Both kinases subunits are inactive as monomeric form and are activated by binding of 
Cyclins for CDK and by Dbf4 for DDK. Recent evidence indicates that  the Mcm2-7 
complex is a target of phosphorylation by DDK and this event is needed for loading of 
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the Cdc45 protein31. Hence, the cooperative action of these kinases trigger the 
recruitment of replication proteins necessary for origin unwinding and DNA synthesis. 
In particular, Cdc6 is released from origins by the cyclin dependent protein 
kinase, CDK2/Cyclin A, and replaced by Cdc45 upon the concert action of Cdc7/Dbf4 
and CDK2/cyclin E complex kinases. Then Cdc45 associates with DNA polymerase α 
and DNA primase and leads to initiate RNA-primed DNA synthesis. 
While DDKs seem to act on MCMs, CDKs appear to play a direct role in 
preventing the assembly of new pre-RCs. Since CDK activity remains high from S 
phase to the end of the following mitosis, re-licensing cannot occur until the beginning 
of the next cell cycle32. At least three members of the pre-RC (ORC, Cdc6 and MCMs) 
are phosphorylated by CDKs to prevent pre-RC assembly and re-replication. Moreover, 
CDKs have also been implicated in controlling the time of replication initiation at 
specific origins26. In this way the activation and inactivation of the proteins restrict 
DNA replication to once and only once per cell cycle. 
The fact that assembly of pre-RC is delayed until mitosis is complete and a 
nuclear membrane is assembled, suggest that nuclear structure plays a role in the 
initiation of DNA replication. Chromatin is looped into domains by attachment of the 
chromatin fiber to the nuclear matrix. DNA sequences that bind preferentially to nuclear 
matrices are named Matrix Attachment Region (MAR) or Scaffold Associated Region 
(SAR), which are supposed to mediate this loop formation in vivo. MARs are about 200 
bp long, AT-rich and contain topoisomerase II consensus sequences. Moreover, they are 
often found near to cis-acting regulatory sequences, and their binding sites to the 
nuclear matrix are abundant (greater than 10,000 per mammalian nucleus). Any DNA 
sequence, including the origins of replication, could be attached to the matrix at a 
certain time during the cell cycle. Indeed, a large body of evidence indicates that DNA 
replication occurs on nuclear matrix but origins are not permanently attached with the 
nuclear matrix suggesting a dynamic association during the cell cycle33. 
Homologues of the indicated proteins were identified in all eukaryotic organisms, 
but the attempts to define an origin consensus sequence, or at least common specific 
features of the origin sequences, lead to the conclusion that no sequence specificity and 
no origin consensus is identifiable. However, DNA replication starts from specific sites 
and with a defined spatial programme. The preparation of this programme is crucial for 
the maintenance of genome integrity, because the disruption of pre-RC formation leads 






















Figure 2. DNA replication in mammalian cells. ORC binds to DNA sequences recognised as 
replication origins. ORC exists in M phase as a stable complex of Orc(2–5) subunits, then ORC1 subunit 
is selectively bound to ORC complex during the M to G1 transition; the remaining ORC subunits remain 
stably bound to chromatin throughout the cell cycle. Cdc6 associates with ORC1, and this ORC1-Cdc6 
complex is present in mitotic cells. In G1 phase, then Cdt1 associated to Cdc6 and loads at least one 
Mcm(2–7) hexamer per replication fork. In mammals, only ORC1 is associated to nuclease-resistant 
nuclear structure during G1-phase and then is released from origin previous to DNA replication initiation. 
Behind pre-RC assembly, DNA replication is initiated by the sequential loading of Mcm10, Cdk2/cyclin 
A that phosphorylate and release Cdc6, Cdc7/Dbf4 and Cdk2/cyclin E that subsequently modify other 
members of pre-RC and finally allow Cdc45 to bring polymeraseα and DNA primase to the replication 
origin DNA, the later enzyme initiates synthesis of the first RNA-primed nascent DNA strands. This 
event marks the beginning of S-phase. Concomitant with DNA synthesis is taking place the inactivation 
of Cdt1 by Geminin and the phosphorylation of MCM proteins. Cdc6 and Cdt1 are then released from 
chromatin and eventually degraded. MCM proteins remain in the nucleus where they are weakly 




1.2 Eukaryotic origins of DNA replication  
 
1.2.1. Replication origins 
 
In multicellular organisms the origins of DNA replication are still not well 
defined. The main difference between prokaryotic and eukaryotic replication origins 
resides in the genome became larger in eukaryotes and the replication of chromosomal 
DNA depends on the activity of many different origins, that have to be activated with 
fine coordination in space and time35, 36. In fact, in higher eukaryotes, respect to the 
yeast, the genome size is about 100 times larger and this requires a bigger number of 
origins to ensure complete DNA replication. The increased number of origins also 
makes their mapping more difficult. 
The discovery of the hexameric ORC complex in all eukaryotes from budding 
yeast to man now provides a strategy to look for the common features of origins of 
DNA replication. Although sequences bound by ORC complex could define the origins, 
differently from what observed for yeast, in Drosophila and human, the ORC complex 
have little or not sequence specificity binding activity37. The flexible sequence 
specificity observed in multicellular eukaryotes, respect to bacteria and S. cerevisiae, 
probably allows more dynamic changes in the organization of the genome and its 
replication. 
If ORC complex does not preferentially bind specific sequences, probably other 
elements drive ORC to the origins. One possibility is that other proteins interacting with 
ORC carry it to a specific sequence. This might occur through the direct interaction of 
ORC with chromatin remodelling complexes or proteins that alter the local topological 
state of DNA, as occur for Epstein-Barr virus (EBV). The EBV origin of plasmid 
replication (OriP) provides an interesting model to study ORC recruitment in human 
cells. EBV is a human herpesvirus that establishes latent infections in multiple cell types 
and this latent form exists as an episomal minichromosome that replicate once per cell 
cycle and segregates similar to the cellular chromosome38. The EBNA1 protein of the 
virus interacts with ORC and with other cellular factors to recruit ORC and contribute to 
OriP replication activity39. By the same approach, it was found that not only the 
interaction with other factors, but also several features of the chromosomes, influence 
the firing of replication origins, as observed for methylation of DNA, that blocks the 
ORC binding and the initiation of DNA replication in X. laevis egg extract40; or histone 
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modifications that influence the activity of replication origins. The same was shown for 
Drosophila ORC binding, that is inhibited by the DNA methylation on GC 
nucleotides40. In addition, Drosophila ORC prefers negatively supercoiled DNA, 
proving that the DNA topology  could be a more important determinant than DNA 
sequence for ORC binding8. 
Thus, even if the proteins involved in eukaryotic DNA replication are conserved, 
the sequences on which they bound are highly divergent because metazoan ORC 
complex exhibit no sequence binding specificity. 
Despite the inability of investigators to isolate an autonomously replicating 
sequence in mammalian systems, approximately 20 mammalian origins have been 
identified. Mammalian origins could be classified in two groups, one containing regions 
referred to as zone of initiation, where replication begins from one or several potential 
sites within a large region of DNA, and the other group including origins where 
replication initiates from a localized site in each cell cycle. 
Many examples of initiation zones exist, including the human rRNA locus, the 
Chine hamster rhodopsin and the DHFR (dihydrofolate reductase) loci. The best 
characterized is the Chine hamster ovary DHFR locus, with at least three primary 
initiation site (ori β, β' and γ) that account for most of the initiation events in this 
region41. Analysis of different DNA segments to drive initiation of replication when 
placed in different chromosomal context, revealed that in high eukaryotes replication 
requires specific DNA sequences that are both close to and distant from the site of 
initiation. Therefore, local sequence alterations can either enhance or repress origin 
activity, but no single consensus DNA-sequence motif is necessary or sufficient for 
replicator activity42. Moreover, by two-dimension gel mapping of a single copy of 
DHFR locus indicated that replication begins from multiple sites spanning 55 Kb 
intergenic region between DHFR and the adjacent locus. Preference for initiation was 
seen inside the central 35-40 Kb region, know to contain oriβ and oriγ43. This study 
suggested that mammalian initiation zone is composed of a primary initiation site 
coupled with multiple lower frequency sites.  
An example of mammalian origin where firing is restricted to a circumscribed site 
is represented by the human β-globin origin. Originally, initiation of replication from 
this locus was thought to start from a single bidirectional origin of replication. Thn, 
more detailed studies indeed revealed that the locus is actually composed of two non 
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overlapping genetic elements that have been described to behave as redundant 
replicators when β-globin origin is assayed as an ectopic chromosomal site44.  
An other example of mammalian replicators is the lamin B2 origin, the best 
characterized among all isolated human DNA replication origins. It was mapped on 
chromosome 19, in the 3' untraslated region of the lamin B2 gene and consists of an AT 
rich region of 70-100 bp that contains 11 bp directed repeats, in one of which a 
bidirectional initiation site was precisely mapped45. Lamin B2 origin displays a cell 
cycle dependent footprint that is longer at G1 and shrinks as cells progress into S 
phase46. Inside this footprint area the transition between leading and lagging strands 
synthesis has been mapped to a single nucleotide level45. Moreover, it was demonstrated 
that cell cycle dependent footprints are in part due to the pre-RC binding. The chromatin 
surrounding the lamin B2 origin in G1 phase is bound by Cdc6, ORC1, ORC2 and 
MCM3, in S phase was found to bind by ORC2 and in M phase none of these pre-RC 
members were detected47. This data suggests that mammalian origins are bound by the 
same replication machinery as found in other eukaryotic systems, and this follow 
similar cell cycle regulation as in yeast. Additionally, this origin remains functional 
when transferred to other positions of the genome. Indeed, a DNA segment from lamin 
B2, comprising the larger footprint region, the start site of DNA replication and a CpG 
island, displays origin activity when moved to different chromosomal positions. This 
data confirm that this region contains a mammalian replicator and support the idea that 
sequence elements close to the replication start site play an important role in origin 
activation48. 
The ORC binding activity was also found in other replication regions like the 
TOP1 origin, which is localized in a GpC island usptream the human TOP1 gene on 
chromosome 2049, and like the MCM4 origin that is located in a genomic region 
overlapping the control elements of the divergently transcribed genes MCM4 and 
PRKDC49. 
Thus, from all these examples of eukaryotic replication origins emerge that 
alternative factors could be responsible for ORC complex recruitment to the origins, and 






1.2.2. Origins spatio-temporal organization 
 
The density of the origins is variable, with a minimum of no origin in 500 kb and 
a maximum of one origin every 11 kb, as the case of HoxA locus. Assuming that most 
origins have similar efficiency, the conclusion is that the genome is replicated by 
extremely variable replicons. In some loci, several origins located close together may be 
activated on the same DNA molecule at the same time50. 
The isolated origins posses a wide range of time for the activation, and it seems to 
act a sort of temporal programme for timing of origin firing, in which the density in 
origin is important but not sufficient to determine the replication time and probably the 
chromosomal environment plays a crucial role in this organization50.  
It was also observed that DNA sequences encompassing multiple replicons result 
to be less sensitive to replicative stress, and important to maintain genome stability. On 
the contrary, those regions with less origins are most sensitive probably due to the lower 
probability to use a backup licensed origin, located in between of two collapsed 
replication forks. 
There is a considerable plasticity in the process of origin activation, because in 
cells whit many potential replication origins, most of them are not systematically 
activated in all cell cycles and only a small percentage are used, while the other remain 
"dormant". The dormant replication origins can be activated when DNA replication is 
slowed down. The usage of replication origins in fact, can change under different 
circumstances, like changes in chromatin organization that directly affect the way in 
which the origins are used in the subsequent cell cycle51. Also the presence of stalling 
replication forks, due to the damaged bases on DNA, can lead to activation of dormant 
replication origins. The dormant origins are activated as consequence of rapid and 
transitory response to several changes, and not affect the long-term behavior of cells. 
Their firing is like an adaptation mechanism of the genome to ensure the efficient DNA 
replication.  
This adaptation correlates both with changes in chromatin organization and 
association of replication origins with the nuclear matrix51. Adjacent replicons are 
replicated together in "factories" with all the DNA replicated in a single factory co-
localized within the nucleus52. This organization probably reflects the attachment of 
specific DNA sequences to an insoluble nucleoskeleton or nuclear matrix, creating in 
this manner chromatin loops that delineate functional defined units of transcription and 
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replication. Moreover, it is known that there is a relationship between the size of DNA 
loop that appear to be tethered to the nuclear matrix and the average spacing between 
replication origins. 
From further observations of discrete sites within the nucleus detected by BrdUrd 
incorporation in mammalian cells at the beginning of S phase appear globular and 
constant in size but then grow and appear to form ring structures, it was concluded that 
the replication takes place at discrete sites in the nucleus and many replicons in a cluster 
might replicate in close proximity. These sites are called replication foci and indeed 
represent regions of DNA containing many replicons53. All studies to date demonstrate 
that in early S-phase replication sites are distributed throughout the nucleoplasm, with 
the exception of regions occupied by heterochromatin or nucleoli, and appear as discrete 
sites of variable size and number. Moreover, foci replication patterns and size of foci, 
change during S phase. In fact, in early S the number of the foci is bigger and their size 
is smaller than those found in mid and late S phase. This suggests that origin firing is 
programmed by a different temporal activation during S phase. In budding yeast, for 
example, the origins are activated principally in mid S phase, but the activation is 
visible throughout S phase54. 
The decision point for the activation of specific origins in metazoan cells is the 
early G1 phase. Therefore, transcriptionally active euchromatin replicates earlier respect 
the inactive heterochromatin, probably because the transcription open the chromatin and 
allows easy access to replication factors. 
 
 
1.2.3. Origin activity and transcription 
 
The relationship between transcription and replication has been documented in 
viral DNA genomes, in which transcription factors participate in the initiation of viral 
DNA synthesis by interacting with the viral initiator55, but the involvement of 
transcription in replication and in regulating temporal activation of origins in eukaryotes 
is still unclear. Several lines of evidences indicate that transcription itself is not required 
for origin function in eukaryotes, but important is the competition between transcription 
and replication. In fact, during S phase in mammalian cells, there is an evident 
separation of the active replication sites and active transcription sites56, indicating that 
transcription processes are stopped during replication. Moreover, it was observed that 
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the β-globin origin is activated both in transcriptionally active and inactive cells, and 
some kind of interferences between transcription and replication can occur when these 
two processes are not in the same orientation. The participation of transcriptional 
elements in site specific initiation of DNA replication might be due to the fact that they 
are part of the organization of chromatin domain competent for transcription57. 
However, replication origins tend to be associated with coding genes and the 
known origins are frequently distributed close the gene promoters. Studies of both 
coding and non-coding DNA regions, have shown that origin density and gene density 
are strictly correlated and reflect the coordinate organisation of replication and 
transcription. This finding suggests that these two processes may have regulatory factors 
in common, indeed it was also observed a strong association between origins and CpG 
islands. CpG islands are genomic regions bound by many transcriptional factors and the 
role suggested for them is the direct or indirect recruitment of pre-RC members for 
regulation of origin selection. In mouse the origins associated with CpG islands result to 
be more efficient because recruitment of the pre-RC proteins is favoured at this sites. 
Moreover, the presence of transcriptional factors at origin sites appear to stimulates 
replication also in others organisms58, 59. This stimulation may be a consequence of their 
direct interaction with components of the replication machinery or recruitment of 
chromatin remodelling complexes that facilitate the access of the replication complexes 
to DNA. Nevertheless, not all active promoters are efficient sites for DNA replication, 
so the active origins associated with transcription regulatory elements have to contain 
additional information. In fact, the sequences containing known origins remain strong 
sites of DNA replication also when inserted ectopically, indicating that specific 
replication starts point are recognized by replication machinery48, 60. Due most probably 
by recognition of specific combinations of transcription factors. 
The CG rich regions seem to be important also for define a timing program. 
Several studies showed that CG rich regions tend to replicate earlier than CG poor 
regions, revealing a strong correlation between regional CG content and density in 
origins. In fact, late-replicating DNA, coincide with AT-rich regions on metaphase 
chromosomes with low transcriptional activity, while early-replicating DNA coincided 
with GC-rich regions with high transcriptional activity. Regions lacking origins, 
typically with a low content of CG, are replicated passively and hence relatively late, 
contrary to regions with high density of origins, that are rich in CG and replicate earier. 
However, in same studies, other regions with high density of origins were not early 
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replicated. The strong correlation observed between origin density and GC richness is a 
consequence of the strong association between origins and promoters or more distal 
transcriptional regulatory elements. Thus, as already said, the CG content and the 
density in origins are not predictive of replication timing and a major role for 
determining a precise spatio-temporal program is probably to ascribe to the 
chromosomal environment50, 61.  
Replication origins are found also in non open chromatin regions, probably bound 
by transcriptional factors that do not alter the chromatin structure. So, as for the 
transcription, probably different combinations of transcriptional factors are involved in 
the regulation of replication initiation sites. In this context, the lack of a consensus 
sequence in DNA replication origins could be explained62. 
So, replication in higher eukaryotes is clearly initiated by the interaction of an 
initiator with a replicator, as the replicon model proposed, but the replicator is defined 
by several features, between which the DNA sequence constitutes only one of the 
elements that influence where DNA replication starts, and the initiator is composed by 
all elements involving in the formation of the replication complex.  
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1.2.4. Chromatin structure influence on origin activity 
 
Since is not possible identify a consensus sequence for origins, it was considered 
the possibility that the chromatin environment and modifications may play a central role 
in DNA origin selection. In fact, multiple structures contribute to eukaryotic replicator 
activity, suggesting that both DNA sequence and chromatin packaging influence 
replication initiation. 
The basic units of chromatin are the nucleosome, octamers of histones, composed 
by two copies of each H2A, H2B, H3 and H4, around which DNA spools with about 
146 bp. They form nucleosomal structures that coiled up to form a fibre of 30 nm 
diameter stabilized by linker histone H1. Iterative folding of these fibres generates the 
mitotic chromosomes. The packaging of eukaryotic genomes into nucleosomes and 
higher order chromatin structure seem to limit the access of replication factors to DNA. 
Now, origins of DNA replication might be delineated by poorly defined epigenetic 
factors, therefore additional information regarding the genetic marks contained within 
the chromatin associated proteins related to origins, known as "epigenome", is 
absolutely required63. 
A connection between the replicons and the chromatin organization came by the 
observation that proteins involved in DNA replication could also be involved in the 
assembly of specific chromatin domains. In fact, the amino terminal portion of Orc1 in 
higher eukaryotes  is able to associate with heterochromatin-associated protein HP1, 
which contains chromo-domains and is known to be involved in heterochromatin 
formation. This binding indicates that ORC might also interact with other chromo-
domain proteins to allow the assembly of replicons in euchromatin. Members of the 
chromo-domain family are the Polycomb group proteins that are involved in chromatin 
organization. The amino terminal portion of Orc1 contains also a bromo-adjacent-
homology domain, conserved from yeast to human, also present in proteins involved in 
epigenetic regulation of transcription57. 
The chromatin environment influences both replication timing and frequency of 
origin activation64. Moreover, a close relationship has been observed between 
replication timing, chromatin structure and transcriptional activity. It was shown that 
early replicating genes could be either expressed or silent, while late replicating genes 
were almost always silent. This correlation between early replication timing and 
transcription was validated in higher eukaryotes also using various types of microarray 
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approaches. Additionally, this approaches showed a correlation between the 
transcriptional activity and the chromatin state. Chromatin indeed, exists in a 
decondensed or condensed state, called euchromatin and heterochromatin respectively. 
The euchromatin contain either actively transcribing genes or potentially active ones, 
and the heterochromatin is transcriptionally silent. 
A regulatory role of chromatin structure in DNA replication was suggested also 
by the effect of chromosomal position on origin activity in Drosophila. It was observed 
that euchromatic domains generally replicates early in S phase whereas heterochromatic 
regions replicates later on65. 
 
 
1.2.5. Histone modification and Trichostatin A 
 
Regulation of chromatin structure occurs through post-translational modifications 
of the histones tails, including acetylation, methylation, phosphorylation, ubiquitylation 
and sumoylation. Post-translational modifications of histone tails are largely 
investigated and also multiple modifications in the structured globular domains of 
histones are recently analysed. These modifications can generate different interaction 
affinities for chromatin-associated proteins and enable a dynamic chromatin state in 
which diverse nuclear processes can occur systematically66. 
Two of the most studied modifications are the acetylation and deacetylation of 
lysines on the core histones, which are controlled by histone acetyltransferases HATs 
and histone deacetylases HDACs respectively. The acetylation state of a chromatin 
locus results from the activities of HATs and HDACs on the nucleosomes. The 
reversible acetylation of the N-terminal tails of histones is a prominent chromatin 
modification that is thought to alter the degree of chromatin compaction. Typically, 
histone acetylation correlates well with increased DNA access, while histone 
deacetylation, and also the histone metylation, correlate with the formation of 
transcriptional silent chromatin. Thus, the result of histone acetylation is a change in 
chromatin structure and a corresponding increase in the accessibility of the DNA by 
trans-acting factors. The enzymatic activities that are required to the access to 
chromosomal DNA then would take benefit from chromatin modification by histone 
acetylation. An example of this mechanism might be the case of the HAT that binds to 
pre-RC complex, HBO1 (histone acetyltransferase binding to ORC1),this enzyme is a 
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MYST domain protein, characterized by a highly conserved zinc finger and a putative 
histone acetyltransferase domain. Data showing association with pre-RC components 
such as ORC1 and MCM2, suggest a role for this histone acetyltransferase protein in 
DNA replication. The presence of this HAT around the origins opens the possibility that 
this factor is recruited to the pre-RC by multiple proteins interactions and propose an 
active process in which chromatin is remodelled by replication initiators67, 68. 
Alterations of HDACs activities were identified in tumor cells and contribute to 
the massive perturbations of gene expression in numerous tumours. HDAC inhibitors 
leads to differentiation, cell cycle arrest and apoptosis in tumour cells and in some 
cases, prevents tumour growth. The most know potent inhibitors of the HDACs is 
Tricostatin A (TSA), which belong to the group of hydroxamic acids and is a natural 
product isolated from Streptomyces platensis. Crystallographic analysis indicate that 
TSA interacts reversibly with the HDAC catalytic site preventing binding of the 
substrate69. 
Histone deacetylase inhibitors in general, represent a new class of targeted anti-
cancer agents. Several of these compounds are in clinical trials with significant activity 
against a spectrum of both hematologic and solid tumors at doses that are well tolerated 
by the patients70. One of the most effective and well studied HDAC inhibitor is the TSA 
itself. 
The importance of chromatin structure in spatially and temporally regulation of 
DNA replication initiation was analysed using TSA treatment itself. The level of histone 
H4 acetylation correlates with the frequency of replication initiation, as measured by the 
abundance of short nascent DNA strands, mostly in the human c-myc and lamin B2 
origins, and quite less with the frequency of initiation across the β-globin locus. Cells 
treated with TSA result in a reversible increase of the acetylation level of histone H4, 
both globally and locally to initiation sites at origins. In all three origins, TSA treatment 
transiently promoted a more dispersive pattern of initiations, decreasing the abundance 
of nascent DNA at previously preferred initiation sites. When cells arrested in late G1 
were released into TSA, they completed S phase more rapidly than untreated cells, 
possibly due to the earlier initiation from late-firing origins. Thus, histone deacetylation 
might modulate replication origin activity through its effects on chromatin structure, by 
changing the selection of initiation sites, and promoting DNA synthesis at dormant 
initiation sites71. 
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Other published data regarding TSA cell treatment lead to the same observation 
that pattern of initiation site selection in a replication loci was altered and becoming 
more dispersive. Thus, preferred initiation sites become less active while the less 
frequently used initiation sites become more active after treatment with TSA. It was also 
shown that the β-globin origin was induced to initiate DNA synthesis earlier in S phase 
after treatment with TSA. Since that in c-myc origin, the redistribution of MCM 
proteins was altered after TSA treatment, it was suggested that histone acetylation is a 
temporally upstream event leading to pre-RC formation or that pre-RC formation 
responds to other effects of TSA72.  
Moreover, the observation that origin identity can change during development, 
strongly supports that epigenetic regulation is central in origin selection. Chorion genes 
of Drosophila have been employed to analyse the relationship between chromatin 
modification and origin activity in metazoan. In this organism the somatic follicle cells 
undergo a developmental transition from genomic replication to continuous re-
replication at 4 different chorion locus, two of them were identified on the X and 3rd 
chromosomes. Nucleosomes at these chorion origins were found to be  hyperacetylated. 
These epigenetic modifications of chromatin contribute to different origin usage during 
the development. In this particular case, widespread acetylation might allows DNA 
access to additional origin binding proteins thereby impaired origin activity, that then 
results in a redistribution of the origins73. This observation is consistent with some 
observation in yeast, indeed mutation in a histone deacetylase resulted in advanced 
activation of late firing origin, and interaction of HBO1 HAT with replication proteins.  
Interestingly, another component of the pre-Rc complex, MCM3, is endogenously 
acetylated and the acetylated MCM3 form is strictly chromatin-bound in late G1 phase. 
Moreover, MCM3 associated protein (MCM3AP), a protein isolated by two-hybrid 
screening using MCM3 as bait, is a specific MCM3 acetyltransferase of the GNAT 
superfamily74. The acetylase activity on MCM3 by MCM3AP is required to inhibit 
initiation of DNA replication and the association of MCM3AP to chromatin alone is not 
sufficient for this inhibition. The interaction between MCM3 and MCM3AP is essential 
for nuclear localization and chromatin binding of MCM3AP. Hence, MCM3AP is a 
potent natural inhibitor of the initiation of DNA replication whose action is mediated by 
interaction with MCM374. 
Thus, chromatin acetylation seems to have an important effect on origin identity 
and activity, probably by relaxing chromatin and allowing proteins to gain access to the 
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origin binding sites. However, the precise step where this modification influences the 
origin activity remains still unclear. Nevertheless, in the chorion locus acetylation 
coincides with ORC binding to newly synthesied fibres and chromatin hyperacetylation 
determines redistribution of ORC2, suggesting that acetylation regulates DNA 
recognition by ORC. 
 
 
1.2.6. Chromatin remodelling factors 
 
In addition to histone modifications, nucleosome repositioning is involved in 
general chromatin remodelling events. Cell cycle changes in histone and in chromatin at 
eukaryotic origins are important regulatory feature controlling replication and access of 
licensing factors to DNA. Consistent with this, it was shown that a depletion of the ATP 
dependent chromatin remodelling complex ACF-ISWI, delayed progression of 
replication in late stage of S phase. ACF (ATP-utilizing chromatin assembly and 
remodeling factor) catalyzes the ATP-dependent assembly of periodic nucleosome 
arrays in vitro, and consists of ACF1 and the ISWI ATPase. ACF1 and ISWI are also 
subunits of CHRAC (chromatin accessibility complex), whose biochemical activities 
are similar to those of ACF. ACF1 forms a complex with the SNF2H isoform of ISWI 
and this complex is localized to pericentromeric heterochromatin during DNA 
replication. The depletion of this complex impairs the replication of pericentromeric 
region indicating the requirement of this complex to enables DNA replication through 
highly condensed regions of heterochromatin in mammalian cells75. The replication 
defect of ACF1 depleted cells was rescue by 5-aza-2-deoxycytidine treatments, which 
causes decondensation of heterochromatin by inhibition of DNA methylation. Although 
it is not known whether SNF2h alone plays a role in chromatin remodeling at replication 
origins or forks, it is worth noting that SNF2h is also recruited to remodel chromatin at 
the Epstein-Barr virus origin where host cell initiation machinery is utilized76. Also in 
Drosophila it was shown that chromatin-remodelling protein is implicated in promoting 
DNA synthesis and chromatin formation. Biochemical experiments with ACF1-
deficient embryo extracts further indicate that ACF/CHRAC is a major chromatin 
assembly factor in Drosophila.  The phenotypes of flies lacking ACF1 suggest that 
ACF/CHRAC promotes the formation of repressive chromatin77. 
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Nucleosome remodelling factors are known to regulate chromatin structure at 
nucleosomal level by ATP-dependent alteration of the interaction between histones and 
DNA78. All these factors have ATPase subunits of the SWI-SNF superfamily. The 
ATPase subunits are related to helicases and are the key to understand the mechanism of 
remodelling. Probably, the interaction of the ATPase with the nucleosome, combined 
with directional translocation of the DNA, leads to a shift of DNA segments relative to 
the histone surface. To induce the sliding of nucleosomes the ATPase requires the 
presence of the basic amino acids at histone 4 (H4) tail. The same residues are necessary 
for the folding of the nucleosomal fibre indicating that nucleosome-remodelling factors 
directly interact with the histone determinants of fibres folding79. 
 
 
1.2.7. Role of DNA topology  
 
Also the topological state of the origin DNA play a fundamental role in regulation 
of DNA replication. It was precisely demonstrated that the topoisomerase I and II 
interact with sequences bound by the replication proteins and close to the start site in the 
lamin B2 origin of replication80. Topoisomerases are enzymes that can modify the 
tertiary structure of DNA without changing its primary structure. The need for these 
enzymes comes from the structure of DNA itself, because during the elongation the two 
fork complexes unwind the double helical accumulating positive supercoils and  
tortional stress. When two replication forks, from adjacent replicons, converge and 
finish replicating the DNA segment, termination occurs. At this stage the two daughter 
double helices need to de separated to ensure a proper sister chromatids segregation.  
Topoisomerases are therefore required to rapidly relax these supercoils and allow 
progression of the replication fork. Topoisomerases must also function to ensure that 
DNA strands are completely unlinked and replicated chromosomes can be segregated to 
daughter cells. 
In the Lamin B2 origin, topoisomerases I and II selectively bind to ORC2 binding 
sites in a cell cycle dependent manner. Additionally, ORC2 interacts with 
topoisomerase II at G1 phase and with topoisomerase I at the G1/S transition. 
Moreover, these particular protein interactions occur when they are bound to DNA 
replication origin, indicating a close association with replication complex. Indeed, 
topoisomerase I was also shown to be essential for replication initiation. These two 
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topoisomerases are never acting in the pre-RC binding area at the same time, so that 
they seem to have specialized functions in the context of topology modulation for 
regulation of origin activity. Topoisomerase II seems to be especially involved in pre-
RC assembly and Topoisomerase I in origin firing. The dynamic interplay between 
ORC topology-modifying enzymes and DNA replication origin throughout the cell 
cycle, demonstrate the importance of DNA topology for the origin regulation. 
 
 
1.2.8. Cruciforms structures  
 
Numerous studies have shown that also the cruciforms structures in DNA, that 
naturally occur as secondary structures, serves as recognition signals at or near origins 
in yeast and mammas81. Stem-loops and cruciforms structures can be formed from DNA 
inverted repeats. These structures are widely distributed in eukaryotes and may affect 
the supercoiling degree of DNA, nucleosome positioning and the formation of other 
DNA secondary structures, or directly interact with proteins. A dynamic distribution of 
DNA cruciforms in mammalian nuclei exists and their number becomes maximal at the 
G1/S boundary. A lot of evidences support the hypotesis that particular inverted repeats 
located in potential DNA replication origins give rise to cruciform structures that serves 
as attachment site for initiator proteins. Probably some cruciform-specific binding 
proteins are involved in regulation of replication82. Thus, the mechanism proposed 
involved cruciform stabilization and recognition by replication initiator proteins. CBP 
and 14-3-3 proteins are indicated as proteins involved in DNA replication through 
binding to cruciform structures. CBP (Cruciform-Binding Protein) was identify for his 
specificity for cruciform DNA regardless of its sequence and was then revealed as a 
member of 14-3-3 protein family. This family is highly conserved and widely 
distributed in eukaryotes, consisting of several isoforms in each species and with many 
functions ascribed. Among the 14-3-3 associated proteins were also identified some 







1.3. Hox proteins 
 
1.3.1. HOX genes 
 
During the development, animals specify many different types of cells. Each cell 
must be developed in the correct context and at in the opportune time. For this purpose 
cells own the genetic information that then are translated into reproducible spatial and 
temporal signals. 
All bilateral animals possess a common genetic mechanism for the regulation of 
the development along the body axis and HOX proteins are among the key regulators in 
the specifying regional identities84, 85. These proteins are transcription factors that act 
during normal embryo development. 
The Hox genes are expressed in defined domains in the anterior-posterior axis and 
the importance of their function in assigning positional identities along the embryonic 
body is evident when an Hox gene function is disrupted, which usually results in 
"homeotic transformations"84,86. The term "homeotic transformations" was introduced 
by Bateson in 1894 and derived from the word "homeosis". It is used to describe the 
transformation of a structure or body segment, in form and shape, into another 
homologous structure present in the body87. 
The genes encoded for the HOX proteins were first identify in the fruit fly 
Drosophila melanogaster. In this organism, mutations in such genes often resulted in 
transformation of the body plan. Initially they were discovered by the observation of 
two dramatic alterations in the fruit fly body, in which after mutation of bithorax gene, 
the haltere balancing organ on the third thoracic segment is transformed into part of a 
wing whereas mutation in the antennapedia gene resulted in transformation of the 
antennae into legs. 
Further studies in Drosophila showed that these genes were found to cluster 
together in the genome, forming two groups with a total of eight genes. A group, named 
Antennapedia complex, regulates the development of the anterior body of the fly and is 
comprised of five genes, whereas the other group, named Bithorax complex, regulates 
the development along the anterior-posterior axis and comprise three genes (Figure 3). 
An important feature of these genes is the collinearity, indeed the gene order in 
the cluster mimics the order of expression of genes and their function along the 
anterior–posterior body axis: genes at the 5′ end of the cluster are expressed in, and 
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pattern the posterior part of the body, whereas genes at the 3′ end pattern the anterior 
end of the body. In some species, homeotic genes also exhibit temporal collinearity in 
addition to the spatial one: anterior genes are expressed first during development and 
posterior genes later. 
The loss of function of any Hox gene allows the expression of other overlapped 
Hox gene, resulting in the transformation of a segment identity of the body towards the 
identity of the neighbouring segment. However, mutations in Hox genes do not always 
determine such strong phenotypes, but they can also cause very subtle defects, as 
frequently observed in organisms with multiple Hox clusters. This is due to the 
overlapping expression and functional redundancy of paralogous Hox genes of different 
clusters. Indeed, individual Hox genes, at least in higher animals, show a degree of 
functional redundancy, possibly caused by the duplication events of the Hox cluster 
described below. Thus, morphologic specification by HOX proteins may also be 
partially determined by the concentration of the single Hox member in a dynamic 
interaction with other HOX proteins88. However, even in organisms with a single 
cluster, as in Drosophila, homeotic transformation are primarily observed after 
mutations in those Hox genes that either have overlapping expression domains or are 
engaged in a negative cross-regulation with other Hox genes85, 89. 
Although first described in Drosophila melanogaster, homeotic transformations 
are found in many other organisms, which led to the conclusion that Hox proteins act as 
principle regulators of morphogenesis.  
The characteristic of these proteins is the homeobox, a highly conserved domain 
in HOX proteins, constituted by a 60 aminoacids motif. The tertiary structure of this 
domain consist of three alpha helices that form an helix-turn-helix motif and an 
additional domain know as the aminoterminal arm, located just adjacent to the first 
helix. DNA contacts are formed primarily by residues 47, 50, 51, and 54 in third alpha-
elices, the so called "recognition helix", and by an arginine in position 5 of the amino-
terminal arm90. This domain enables the homeobox proteins to bind to DNA at specific 
binding sites and activate the transcription of their target genes. The rest of the protein 
may be very different, but this homeobox motif is crucial for its function. In some cases, 
however, the specificity also required non homeodomain residues, in particular, those 




1.3.2. Hox cluster in Drosophila and Human 
 
The Drosophila species contain eight homeotic genes distributed in two groups: 
the Antennapedia cluster is comprise of the five genes lab, pb, Dfd, Scr and Antp, 
whereas the Bithorax cluster comprise the three genes Ubx, Abd-A and Abd-B. The 
name of the genes was given based on the phenotype. If the first mutant isolated was 
dominant the symbol of the gene begins with capital letter as for Dfd, Scr, Antp, Ubx, 
AbdB and if the first mutant isolated was recessive the small letter as for lab, pb adbA. 
Actually, several other genes containing the homeodomain have been isolated from the 
Drosophila genome at later stage and are more commonly reffered to as homeobox 
genes. 
The mammalian Hox genes family consists of 39 genes organised in four clusters 
labelled A, B, C and D, located on four different chromosome in the genome, 
respectively the chromosome 7, 17, 12 and 2 and numbered from 1 to 13, although no 
cluster contains a full set. They are structural and functional homologues of the 
homeotic complex of Drosophila and are thus thought to have arisen by two separate 
duplication events. For their homology with Drosophila homeotic genes, group 1 to 8 
are considered analogous to the antennapedia (Antp-like) and group 9 to 13 to the 
abdominal-B (Abd-B like) ones. It is believed that the evolutionary amplification of the 
Hox genes started with a cis-amplification of a primordial Hox gene, producing 13 
members, which was followed by a trans-duplication of most of the Hox cluster. The 
trans-duplication is further believed to have occurred twice, leading to the four Hox 
cluster present in mammalian genome. 
These duplication events have had a direct consequence on the striking homology 
shown by the 39 Hox genes. The genes occupying the same relative position along the 
5' to 3' chromosomal coordinate share a higher degree of sequence similarities than the 
genes occupying adjacent positions on the same chromosome. Indeed, for example, the 
comparison of the homeodomain sequence of HOXA1 with HOXB1, that have the same 
coordinate on different chromosomes, and both HOXA2 and HOXA13, distant but on 
the same chromosome, shows that HOXA1 presents an ~88% of homology with 
HOXB1, the ~67% of homology with HOXA2 and only ~48% with HOXA13. 
The homeobox genes were first identified as developmental regulators and much 
attention was given to their functional role in embryogenesis and early development. 
Then, it has became clear that these regulatory genes are also active in normal adult 
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cells, where the expression of homeobox genes is somehow related to controlling 
cellular identity and regulation of genes necessary for cell division, cell adhesion and 
migration, morphological differentiation and apoptosis in metazoan cells. Several 
downstream targets of the HOX proteins in fact, play multiple roles in several pathways, 
mainly acting as transcription factors and regulating their own subset of genes. HOX 
proteins also participate in the regulation of expression of some binding cofactors that 
influence HOX genes expression.  
As during the development, adult cells also possess a tissue-specific Hox gene 
expression characteristic of a specific organ tissue. This tissue-specificity expression 
might be responsible for the organ specific phenotype and for the positioned in the 
biaxial enviroment. The maintenance of HOX expression in adult stages depends on the 
action of Polycomb Group proteins, which are believed to restrict HOX expression to 
lineages in which the genes were initially activated. The Polycomb Group proteins act 
through epigenetic effects on chromatin structure. Another regulator of the activity of 
HOX proteins is Geminin. The ability of Geminin to block HOX function is linked to 
the interactions with HOX proteins themselves as well with Polycomb group proteins, 
wherewith forms multi-protein complexes that regulate chromatin structure to repress 
gene expression.  
There are also a number of divergent homeobox genes present in both 
invertebrates and vertebrates. Their common feature is the presence of the 
homeodomain and the involvement in development and cellular differentiation, but 
differently to the Hox genes, they are located randomly at various chromosomal loci. 
 
 
1.3.3. HOX and its cofactors 
 
All the homeodomain-containing proteins seemingly recognise and bind to DNA 
without a stringent  sequence specificity. All the HOX protein family bind to a very 
similar set of AT-rich DNA-binding sites. This poorly specificity in sequence 
recognition exhibited most in vitro, is probably due to the high conservation of the 
homeodomain. As a consequence of an almost invariant three-dimensional structure of 
the homeodomain, the majority of HOX proteins preferentially recognize a conserved, 
but fairly unspecific, ATTA motif92. Clearly, the presence of this rather common 
sequence cannot be sufficient for HOX regulation. Moreover, the same motif is readily 
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bound also by many non-HOX proteins, thus raising the question of how specificity is 
achieved. 
Structural analyses revealed the mechanism used by HOX proteins to select 
specific binding sequences in vivo showing that HOX proteins recognize generic HOX-
binding sites through the helix-turn-helix that bind DNA major groove, with an 
additional contact in the minor groove through the aminoterminal arm90. The selection 
among sites is critically dependent on minor groove interactions determined by 
positively charged aminoacid residues located in the aminoterminal arm of HOX 
proteins93. 
This low DNA-binding specificity however, strongly contrasts with the highly 
specific effects showed for HOX transcription factors. One well established way of 
HOX proteins to achieve specificity in vivo is to bind DNA cooperatively with other 
DNA binding cofactors. These other factors influence and determine the specificity of 
the HOX proteins. Many data, in fact, suggested that multiple domains within the HOX 
proteins are essential for the in vivo specific DNA-binding94, 95. Thus, the emerging idea 
is that HOX proteins would heterodimerize with many other factors and from these 
interactions result their sequence selectivity and specificity in DNA-binding. Thus, the 
more stringent selectivity in DNA binding observed in vivo, respect the relaxed one 
showed in vitro, is probably due to the cooperation with other proteins. 
The factors involved in the specificity of the HOX proteins are called cofactors. 
These cofactors may reveal intrinsic latent specificities to the individual HOX 
proteins96. This would also partially explain the increase in binding affinity by HOX 
proteins bound to DNA in conjunction with cofactors compared to binding affinities of 
HOX monomer. The cooperative binding of HOX proteins with cofactors induces 
conformational changes revealing novel, specific binding properties of the complexes to 
their DNA targets. 
The first cofactor identified in Drosophila was Extradenticle Exd. Mutations in 
the exd gene were originally identified as causing homeotic transformations of specific 
body segments in the fly, without altering the expression patterns of the HOX genes 
themselves97. Thus, Exd function together with HOX proteins to alters the 
morphological consequences of their activities. Exd encodes a divergent homeodomain 
protein related to a vertebrate protein Pbx1, that was independently identified by 
mutations that leads to human preB cell acute lymphoblastic leukemia98. Also some 
HOX proteins are involved in human leukemia. In both cases, genetic rearrangements 
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lead to the formation of chimeric proteins that retain the ability to interact each other 
and to bind DNA. The inappropriate expression of the chimeric Pbx or HOX proteins 
causes aberrant proliferation of hematopoietic progenitors and leukemic 
transformation99-101. This cooperative role of Hox and Pbx in leukemic cells may reflect 
a cooperative role for these two proteins in promoting cell proliferation during normal 
development.  
Pbx was the first characterised Hox cofactor. In vitro, Pbx/Exd cooperates with a 
broad subset of Hox proteins to bind a paired recognition element on DNA with high 
specificity. The cofactors interactions are dependent on a hexapeptide sequence 
containing four specific core residues (YPWM) located in aminoterminal of the Hox 
paralogue groups 1-8. Hox paralogue groups 9-10, which lack the consensus sequence 
(YPWM) also cooperatively bind to DNA with Pbx1 with binding dependent on a 
conserved trp residue102. Exd and Pbx belong to the PBC subclass of TALE (three-
amino-acid-loop-extension) homeodomain proteins.  
The TALE proteins are divided in two groups, PBC family and Meis family. Meis 
is another cofactor belong to the Meis family, which acts as a DNA binding patner for 
the remaining paralogue groups 11-13103. TALE family homeodomain proteins also 
carry out many HOX-independent functions in vivo104. Since they have both HOX-
dependent and HOX-independent functions, the genetic analysis of TALE family genes 
needs to consider that only a subset of the observe phenotypes is due to their role as 
HOX cofactors. 
Pbx proteins interact with Meis/Prep family members in a DNA independent 
manner through highly conserved domains present in the aminoterminal region of these 
proteins105. In contrast, Pbx-HOX interaction appear to be more complicated involving 
the direct contact between TALE motif in Pbx and YPWM of HOX proteins106. For the 
HOX proteins that do not have the YPWM motif, there is a conserved W residue that 
plays an important role in this protein-protein interaction103. Moreover, some data, 
suggest that Pbx proteins may have other ways of interaction with different HOX 
proteins that are alternative to the classical YPWM-TALE interaction107, 108. 
Evidences suggest that Meis/Prep proteins are also required for normal function of 
Hox proteins. Hox-Pbx binding site is often associated with Meis/Prep sites, and 
Meis/Prep bind these sites in cooperation with Hox and Pbx in vitro109. 
The in vivo effects of cofactors binding on HOX function are still controversial. 
Depending on the target, HOX-Exd or HOX-Pbx complexes can act as transcriptional 
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activators or as transcriptional repressors. This has suggested that transcriptional effect 
is determined by the recruitment of other factors into the complex depending on the 
specific regulatory sequence involved or on extracellular signals110. 
Although cofactor binding clearly affects the specificity of Hox for DNA binding, 
the effect on DNA binding affinity differs for different Hox proteins. For some Hox 
proteins, interaction with Pbx confers vastly increased DNA binding affinity, whereas 
for others the interaction appears to have a minimal effect106. 
Given the high degree of specificity required for some HOX functions, and that 
there are many HOX genes in vertebrates, the HOX cofactors identify up to now are 
relatively few. This is also because, especially in vertebrates, multiple Pbx and 
Meis/Prep genes encode for proteins with different biochemical properties and thus 
expand the number of HOX cofactors. 
HOX proteins used these cofactors to both activate and repress target genes, 
raising the question of how gene activation versus repression is determined. One 
possibility is that the presence of additional factors bind to HOX-targeted elements and 
contribute to their activities. These accessory factors are called " collaborators". 
Because HOX proteins work in many different developmental contexts, it is likely that 
HOX collaborators may include a very large number of different proteins, such as 
transcriptional effectors that are downstream of cell-cell signaling patways. Perhaps the 
ability of HOX proteins and Pbx-HOX dimer to interact with a large number of different 




































Figure 3. Alignment of Human with Drosophila HOX genes. The four clusters of Hox genes in 
vertebrates have arised by two duplication events of Drophila cluster, known as A, B, C, and D. Based on 
sequence similarity the genes can be sorted into 13 ‘paralog’ groups. The order of paralogs along the 
chromosome is preserved in the four complexes. The genes within a complex are transcribed in the same 
direction and are numbered according to their paralog group from 1 at the 3′ end to 13 at the 5′ end. In 
several cases a member of a paralog group is absent from a complex, in this case the corresponding gene 





1.4.Hox genes and cancer 
 
1.4.1. Hox as oncogenes 
 
The so called "oncogenes" are normal genes that cause cancer when their 
expression or function became aberrant and contribute to the development of a 
neoplasia. Generally, these mutations are dominant in that the oncogenic consequences 
can be manifest in the continue presence of the normal gene product. In some cases, the 
elevated or untimely expression of the normal gene product is sufficient to convert a 
normal gene in an oncogene. 
Many oncogenes encode important proteins involved in cellular growth and 
differentiation, including transcriptional factors. Among these are the members of Fos 
and Jun family, transcriptional factors largely studied for the frequent overexpression of 
these genes in human tumours and in tumour cell lines. The overexpression of these two 
factors brings to cell transformation. In addition, Fos and Jun may play an important 
downstream role in transformation together with other activated oncogenes. Also MYC 
proteins, a family protein commonly associated with transcription factors, result to be 
involved in a large number of neoplasias. MYC has been studied in depth because it is 
involved in a large number of neoplastic conditions as well as for its contribution in cell 
growth regulation. In many cases, the chromosomal translocations cause a deregulation 
in MYC gene expression, as in the Burkitt's lymphoma and in AIDS associated 
lymphoma and T leukaemias112. 
Several lymphoblastic and myeloblastic leukaemias have cytogenetically visible 
rearrangement on chromosome 11q23. The gene on chromosome 11q23 has been called 
MLL and present homologies with the Drosophila homeotic trithorax gene. As 
trithorax, also MLL encodes for a protein containing a series of zinc-finger motifs and 
seems to be a mammalian homeobox gene. In all cases studied so far, its translocation 
generate fusion proteins that are involved in malignancies derived from hematopoietic 
lineages113. The fusion products often involved transcriptional regulators which can 
regulate the cell future. The chromosomal rearrangement involving MLL with 
homeobox protein CDX2 regulator, or the translocation of the Pbx1with a cofactor of 
HOX proteins, lead to an aberrant expression of HOX genes found in malignant cells, 
supporting in this way the involvement of the HOX genes in human leukaemia114-116. In 
leukaemia, in fact elevated levels of HOX genes have been frequently observed.   
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Homeobox transcription factors are known to be involved in both cells 
proliferation during early development and in cell differentiation. To control these two 
processes, homeobox proteins act regulating the cell cycle progression and, in many 
cases, interacting with factors of the cell cycle machinery. Since it is widely accepted 
that the process of normal development and oncogenic transformation have a great deal 
in common, it is quite predictable that homeobox genes have been often found 
deregulated in cancer cells, where they can contribute to the shift between 
differentiation and cell proliferation. 
The first indication of a link between HOX proteins and activation of replication 
origins, and hence with proliferation and cancer, is represented by the protein Geminin. 
Geminin is involved in embryonic development by interacting with the Polycomb 
complex that represses HOX genes, or by direct binding with HOX proteins. HOX, and 
the others homebox proteins, compete with Cdt1 for the binding to Geminin. The 
binding of HOX proteins inhibits the expression of genes important for morphogenesis 
preventing the binding of HOX with DNA, while the binding of Cdt1 repress DNA 
replication and cell proliferation. When HOX is bound by Geminin, Cdt1 is displaced 
from its complex with Geminin itself117. Thus Geminin, playing multiple roles in 
several fundamental cellular processes including proliferation, differentiation, 
development and transcriptional regulation, appear to be critical in the strict 
coordination that occurs between embryonic patterning and the cell cycle. Geminin 
represent in this way a connection of HOX proteins function and DNA replication 
origin regulation, apparently also without a direct contact of HOX proteins with the 
origins. Indeed Geminin has no affinity for DNA and his connection with the origin is 
due to the binding of Cdt1. On the contrary, many data show that HOX proteins can 
bind directly the replication origins and the proteins involved in DNA replication118. 
Important indications of a connection between HOX proteins and cell 
proliferation, from which derives also the connection with cancer, were obtained using 
two different systems namely Xenopus embryo and retinoic acid-induced differentiation 
of pluripotent mouse P19 cells. It was shown that the first cell cycles following the mid-
blastula transition in Xenopus are necessary and sufficient for HOXB activation, 
whereas later cell cycles are necessary for the correct expression of those genes. 
Similarly, in P19 cells, HOXB expression requires proliferation, and the entire locus is 
activated within one cell cycle. The activation of HOXB genes is colinear within a 
single cell cycle and concomitant with S phase. Thus, induction of HOXB genes occurs 
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in a DNA replication-dependent manner and requires only one cell cycle. Furthermore, 
in undifferentiated mouse P19 cells were detected several DNA replication origins in 
the 100 kb HOXB locus, indicating a relaxed origin use when the locus is 
transcriptionally silent. After the differentiation of the cells, when HOXB transcription 
is activated, a general silencing of DNA replication origins occurs in the locus except 
one located downstream of HOXB1, at the 3' boundary of the HOXB domain. Silencing 
of the replication origins is associated with histone hyperacetylation, whereas the active 
HOXB1 origin persists as a hypoacetylated island. These findings provide direct 
evidence for the differentiated use of origins in HOXB genes that might contribute to 
the regulated expression of HOXB genes during development119. 
Evidence for the role of HOX proteins in oncogenesis came from the retrovirally 
activated gene HOX 2.4 in NIH 3T3 fibroblast clones that produce fibrosarcomas in 
nude mice and from the observation that a translocation involving human chromosome 
10, band q24, in a subset of T-cell acute leukemias, disrupts a region surrounding the 
putative oncogene HOX11120, 121. 
Many studies show that either loss of function or gain of function of homeobox 
genes may be involved in neoplastic transformation. In the majority of the cases, where 
the expression of a particular homeobox gene is associated with malignant 
transformation, this gene is also expressed during embryogenesis in development tissue 
later affected122. 
Overexpression of HOX genes in mouse bone marrow cells provided additional 
evidence of their role in specifically regulates different stages of hematopoietic 
development. Indeed, overexpression of HOXA10 gene showed that it affects myeloid 
differentiation, leading to myeloid proliferative disease or leukaemia123. 
 
 
1.4.2. HOX, NUP98 and leukaemia 
 
HOX genes are involved in the pathogenesis of human leukaemia also through 
chromosomal translocations of HOX itself. HOX genes are in fact also the most 
common fusion partners of nucleoporin NUP98 in a growing list of identified NUP98 
fusions in patients with acute myeloid leukaemia AML and chronic myeloid 
leukaemia124. AML is characterized by the uncontrolled proliferation of myeloid cells 
that accumulate at different stages where their further differentiation is blocked.  
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NUP98 gene encode for the NUP98 protein, a nuclear core complex that 
transports proteins and RNA/protein complexes between the nucleus and the cytoplasm 
and it is frequently involved in primary and therapy-related hematologic 
malignancies125. NUP98 has great propensity to form fusion genes, particularly with the 
member of HOX gene family and the rearrangements between these two genes are the 
cause of acute myeloid leukaemia. In this aberrant fusion protein, the resulted product 
have the amino-terminus of NUP98 containing a region of phenylalanine-glycine 
repeats attached with the carboxy-terminus of the HOX protein, containing the intact 
homeodomain. Not all Hox genes formed strong leukemogenic NUP98 fusion genes, 
but under certain circumstances, such as increased of the cofactor Meis1 expression, all 
induced myeloid leukemia.  
Decisively, the Abd-B-like Hox genes formed NUP98 chimeric proteins with the 
greatest impact both in proliferation and differentiation in vitro and in leukemogenic 
potency in vivo, which may account for the fact that up to now, only HOX genes 
belonging to this group have been found rearranged with NUP98 in human leukemia. At 
the beginning of these type of studies, HOX partners for NUP98 appeared to be all Abd-
B like genes, including HOXA9, HOXA11, HOXA13, HOXC11, HOXC13, 
HOXD13126-129. Nevertheless, the data reported about the leukemogenic potential ability 
of the Antennepedia-like genes, HOXB3 as fusion partner of NUP98 indicate that this 
ability is not restricted to Abd-B like group, but rather is determined by the intrinsic 
leukemogenic potential of the HOX protein itself. In fact, this property is not observed 
using another Antennepedia-like genes like HOXB4. The potent leukemogenic activity 
of Abd-B-like HOX genes is correlated with their strong ability to block hematopoietic 
differentiation while coexpression of the HOX cofactor Meis1 alleviated the 
requirement of a strong intrinsic HOX-transforming potential to induce leukemia. These 
observations support a model in which many if not all HOX genes may have the 
capacity to contribute to leukemic transformation, presumably reflecting a fine 
regulation in common pathways130. 
HOXD13 is one of the HOX genes involved in AML and his involvement in the 
induction of tumor is not limited to the hematopoietic system, but its deregulation of 
expression has been detected in breast cancer, melanoma, cervical cancer and 
astrocytomas131. 
Thus, the fact that the ability to form leukemogenic NUP98-HOX fusion genes is 
not restricted to the already identified HOX genes but it could be a common feature of 
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almost all the HOX genes, probably is due to the derivation from a common ancestor. 
Their homeodomains are closely related, which may indicate that their redundant 
function in leukemogenesis is mediated through regulation of a similar or overlapping 
set of genes and pathways that control hematopoietic cell growth and differentiation.  
In attempt to reach a molecular classification of leukaemia, using DNA 
microarray, HOXA9 was identified as a predictive marker for the diagnosis of AML. 
HOXA9 expression was the only one among the many tested gene that showed a strong 
correlation with clinical outcome and its expression was also correlated with treatment 
failure in patients with AML132. HOXA9 and Meis are commonly co-expressed in 
myeloid cells lines and in samples from patiens with AML, of all type except 
promyelocytic leukaemia133. 
The long latency observed in HOX-induced AML in mouse model strongly 
indicates that additional genetic events are required for full leukemic progression134. 
Indeed, many data suggest that HOX fusions, as well as most transcriptional factors 
fused with oncogenes, alter the growth and the differentiation of early hematopoietic 
precursors leading to the establishment of a pre-leukemic population of cells that are 
then susceptible to the acquisition of cooperative mutations135. This idea is reinforced 
by the finding that the overexpression of Meis cooperates with multiple native and 
NUP98-HOX fusion genes to accelerate the onset of AML130. Meis is not leukomogenic 
by itself, but its important role in normal hematopoiesis is supported by its preferential 
expression in the hematopoietic stem cells compartment134 and by the multiple 
hematopoietic defects observed in Meis deficient mice136. 
 
 
1.4.3. Oncogenic potential of homeobox genes 
 
While the role of Hox genes in leukaemia is well defined, the oncogenic potential 
of some specific Hox genes in neoplasias is currently being studied. In many forms of 
cancers, chromosomal translocations lead to the creation of fusion genes that acts as 
proto-oncogene. Numerous reports have identified differences in Hox genes expression 
between normal and neoplastic tissues, but there are relatively few studies illustrating 
their function in cancer and the Hox genes functional relationship with the malignant 
phenotype is still elusive.  Useful information has been achieved by monitoring 
biological responses in models in which the expression of a specific Hox gene has been 
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altered. These experimental approaches have widely recognized limitations and are 
complicated by the functional redundancy present in Hox gene system. For the same 
reason, in vertebrates, mutations in single Hox gene do not cause dramatic alterations in 
morphogenesis, differently from what observed in Drosophila. Indeed, gene duplication 
results in multiple members of each paralog group and therefore a significant degree of 
redundancy of the HOX organization. Moreover, vertebral morphogenesis depends on 
quantitative effects of HOX proteins on many effectors genes, while in Drosphila the 
proteins encoded by Hox genes regulates only a few downstream effectors which are 
sufficient to trigger alternative developmental pathways within each segment. 
Abnormalities of homeobox gene expression were identified in many solid tumors 
and in cell lines derived from them. Three different categories of homeobox gene 
expression have been identified in malignancy. In the first, the homeobox genes 
expressed only during the development are re-expressed in neoplastic cells. This result 
in a gain of expression that is seen in many primary tumours and cell lines such as brain, 
mammary gland and kidney in which the homeobox are expressed during the 
embryogenesis. In the second category, homeobox genes are expressed in malignant 
cells derived from tissue in which a particular gene is not expressed during 
embryogenesis. In this case a new activity occurs in the cells, as in the case of PAX5 
expression in medulloblastoma but not in cerebellum, that is the tissue from which 
PAX5 derived. The third category is the one where the homeobox genes are down-
regulated in malignant cells derived from tissue in which a particular gene in normally 
expressed in the differentiated state. This is the case of the loss of expression of CDX2 
and NKX3.1 in colon cancer137. 
Malignancy is associated with the failure of the cells to differentiate and several 
homeobox genes have been found to be involved with terminal differentiation. Over-
expression of some HOX genes is associated with loss of differentiation, as in human 
prostate cancer where the over-expression of HOXC8 is associated with loss of tumour 
differentiation in human prostate cancer suggests that HOXC8 may play a role in the 
acquisition of the invasive and metastatic phenotype of this malignancy138. 
Some data also indicate a relationship between metastatic potential of melanoma 
cells and the expression of integrins, ICAM-1 and HOXC genes. In fact, in clones with 
high levels of integrins and ICAM-1 there is no detectable expression of HOXC locus. 
On the contrary, in clones with low levels of integrins and ICAM-1, the HOXC genes 
are actively express indicating an inversely related expression of HOX genes respect the 
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genes involved in the interaction between cells and between cells and matrix. Cells with 
low levels of proteins involved in these interactions are expected to have an higher 
metastatic potential. HOX gene expression reflects the intra-tumor heterogeneity of 
cancer cells and suggest that the expression of surface molecules involved in cell-cell 
and cell-matrix interactions may be related to the patterns of HOX gene expression139. 
 
 
1.4.4. Role of HOX-Pbx interaction in cancer 
 
Despite the growing body of data implicating HOX genes in the development of 
various cancers, little is known about the role of HOX-Pbx interactions in the regulation 
of proliferation and induction of transformation of mammalian cells.  
The first indication about a relationship between HOX proteins and cell 
proliferation come from a study in which was analysed the Pbx homeobox protein, also 
described in translocations in human leukemias, and its cooperation with HOX proteins 
as cofactor to the DNA binding. It was observed that, in rat cells, cellular transformation 
and proliferation induced by HOXB3 are greatly modulated by the levels of available 
Pbx1 present in these cells and that the transforming capacity of this HOX protein 
depends on his conserved tetrapeptide and homeodomain regions which mediate 
binding to Pbx and DNA, respectively. Taken together, results of this study demonstrate 
that cooperation between HOX and Pbx proteins modulates cellular proliferation and 
strongly suggest that cooperative DNA binding by these two groups of proteins 
represent the basis for HOX-induced cellular transformation140.  
Furthermore, normal Pbx1 homeodomain protein, as well as its oncogenic 
derivative, E2A-Pbx1, binds the DNA sequence ATCAATCAA cooperatively with the 
murine HOXA5, HOXB7, HOXB8, and HOXC8 homeodomain proteins, which are 
themselves known oncoproteins, as well as with the HOXD4 homeodomain protein. 
Cooperative binding to ATCAATCAA required the homeodomain-dependent DNA-
binding activities of both Pbx1 and the HOX partner. It was found that HOXB8 
suppressed transactivation by E2A-Pbx1 suggesting that oncogenic mechanisms of 
certain HOX proteins may require their physical interaction with Pbx1 as a cooperating 
DNA-binding partner141. The importance of Pbx-HOX interaction, which inhibition 
could be a strategy to control the abnormal proliferation of the cancer cells, for 
determining the cancerous phenotype is indicated by the effects of the disruption of this 
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interaction using specific small molecules containing a second homeodomain, that 
modifies HOX activity and act as antagonist of the interaction between HOX proteins 
and Pbx142.  Another small designed peptide amphiphile (PA) which self-assembles into 
micelles, shows inhibition of pancreatic cancer cells, leukemia cells and melanoma 
cells, while non-cancerous fibroblast NIH 3T3 cells are less affected. This molecule 
contains critical regions designed to disrupt HOX-Pbx-DNA complex formation and 
significantly enhances the effectiveness of the molecule to slow cell proliferation143. 
In the case of genes corresponding to the Abd-B like, the same cooperation is 
observed with Meis cofactor. The Meis homeobox gene was identified as a common site 
of viral integration in myeloid leukemias arising in BXH-2 mice. These integrations 
result in constitutive activation of Meis1. The Abd-B like HOXA9 is frequently 
activated by viral integration in the same BXH-2 leukemias. HOXA9 protein physically 
interacts with Meis1 proteins by forming heterodimeric complexes on a DNA target. 
Also Hox proteins from the other AbdB-like paralogs, HOXA10, HOXA11, HOXD12 
and HOXB13, form DNA binding complexes with Meis, while HOX proteins from 
other paralogs do not appear to interact with Meis proteins103. 
Given all these observations, the direct involvement of these transcription factors 
in the start of DNA replication, both in regulation of expression of target genes coding 
for replication protein and in oncogenesis have began to emerge. 
 
 
1.5. HOX and DNA replication 
 
Regulation of eukaryotic DNA replication involves a large number of factors. 
Most of these have been identified, as seen before, and appear to be conserved among 
many organisms144. The studies regarding these main factors however, did not lead to a 
complete elucidation about the mechanisms regulating the DNA replication. Thus, this 
suggests the presence of other elements operating in origin activation and regulation. In 
order to identify new proteins participating in DNA replication, a yeast one-hybrid 
screen for human proteins was used145. The probe used for this screening was a portion 
of the human origin of DNA replication lamin B2.  
Lamin B2 origin is located near the 3' end of the lamin B2 gene, close to the 
promoter of the housekeeping gene TIMM13 on the short arm of chromosome 19 and it 
is currently the best characterized human origin146. It was shown that 1.2 kb of the lamin 
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B2 replicon promotes initiation of DNA replication when integrated at ectopic positions 
of the human genome and that the activity of the origin depends on a 290 bp48. It is an 
early firing origin which has been shown to be active in a variety of normal and cancer 
cell-lines and to be covered by a proliferation-dependent footprint which varies 
dynamically with the cell-cycle147. Indeed, in vivo footprinting studies of the lamin B2 
origin identified a protected area within the 290 bp sequences, due to the binding of 
proteins involved in DNA replication, that changes during the cell cycle. As expected 
for a complex involved in origin activation, the protected area is absent in quiescent 
phase G0, because the incompetence for proliferation in the resting cells. This covered 
area increases in G1 phase becoming particularly evident in G1/S border, where the 
protection is extended for 110 bp, and shrinks in S phase, after origin activation, 
measuring approximately 74 bp. Then, the protection remains unchanged until the M 
phase when disappears, and reappears in the ensuing G1 phase46. Within the protected 
area, were identify in both the G1 and S phases, the transition points between 
continuous and discontinuous DNA synthesis for upper and lower strands, that represent 
the start sites. The start site of the leading strand in lamin B2 origin, correspond to a 
single nucleotide overlapping by four nucleotides on the complementary lagging 
strand45. Furthermore, in-vivo studies have shown that the human ORC1, ORC2, Cdc6 
and MCM3 proteins, are in direct contact with this origin sequence at different moments 
of the cell cycle47. Nucleotide-level investigation, shows the position bound by the 
ORC1, ORC2 and Cdc6 proteins at the origin, throughout the cell cycle. In M phase, 
accordingly with the lack of covered area at the origin, none of these proteins were 
found on the DNA46. In the middle of G1 phase, ORC1, ORC2 and Cdc6 are located at 
the lamin B2 origin as part of the pre-replicative complex. In the middle of S, after the 
origin firing, only the ORC2 protein is still bound on the DNA, moreover its position 
has been shifted closer to the start-site47. 
In the one-hybrid screen, a protected sequence of 74 bp located within the origin 
area in S phase, was used as a probe to search for proteins able to specifically interact 
with the lamin B2 origin. The one-hybrid system is a highly stringent method of 
selection. To be selected a protein must be able to interact with the target sequence 
despite the large excess of unspecific binding sites in the used system. Moreover, 
binding has to occur in the presence of histones and other DNA-binding proteins that 
could hamper the recognition of the sequence by the protein. Thus, the selected proteins 
have doubtless a high affinity binding for the 74 bp sequence used as probe.   
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The identified proteins with this approach were three homeotic proteins, all 
orthologues of the product of the Abdominal B gene of Drosophila, namely HOXC13, 
HOXC10 and HOXA13. To validate the affinity between these homeotic proteins with 
the probe from lamin B2 origins, recombinant HOXC13 and HOXC10 were challenged 
in electrophoretic mobility shift assay EMSA, and both the proteins resulted able to bind 
specifically the 74 bp sequence. In addition, the ability of HOXC10 and HOXC13 to 
increase the activity of a promoter containing the 74 bp sequence, as assayed by CAT-
assay experiments, demonstrates a direct interaction of these homeoproteins with the 
origin sequence in mammalian cell milieu145.  
The level of HOXC10 were analysed in different phases of the cell cycle and an 
oscillation was observed. It was shown that HOXC10 levels are reduced in early G1 
phase, abundant from mid-G1 to G2 phases and became undetectable in mitosis. This 
protein in fact, is targeted for degradation in early in mitosis, when it is ubiquitilated, by 
the proteasome pathway. Mitotic proteolysis of this protein appears to be regulated by 
the APC. It was also show that failure of HOXC10 destruction causes mitotic 
accumulation by delaying the metaphase to anaphase transition suggesting novel 
function of a HOX family member in cell cycle progression. 
About HOXC13 another confirmation of this interaction came from an in vitro 
analysis using nuclear extract in which, by immunological detection, was observed a 
specific binding between HOXC13 and the origin DNA on agarose beads148.  
The interaction of HOX proteins with the origins has been already described also 
for HOXA13, HOXC10, HOXD11 and HOXD13145, 149and in all these cases, depletion 
of these proteins is compatible with cell cycle progression, probably because the 
redundant expression of homeotic proteins.  
HOXC13 is expressed in vibrissae, in the filiform papillae of the tongue, and in 
hair follicles throughout the body. Mice carrying mutant alleles of HOXC13 have been 
generated by gene targeting and it was shown that they have defects in hair, vibrissae, 
nail, and filiform papilla development as well as in caudal vertebrae, but the mouse are 
still viable. 
Similar to both HOXA13 and HOXD13 mutants, HOXC13 mutants also show an 
alteration in the limb. Whereas both HOXA13 and HOXD13 mutants have alterations in 
the phalanges as well as other limb bones, however, the limb defects of HOXC13 
mutants are restricted to the nails, which are derived from ectoderm while the 
expression in the limb appears to be ectodermal.  The HOXC13 gene is expressed in 
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each of these areas, even those well outside the area expected for a paralogous group 13 
gene, suggesting that the defects seen in each of these regions are defects directly 
attributable to a developmental program controlled by HOXC13105 . 
The function suggested for these HOX proteins in DNA replication is concerns 
the promotion of the pre-RC assembly and the stimulation, in a DNA-binding dependent 
manner, of replication. Indeed, a direct role in promoting DNA replication origin 
licensing and replication initiation was observed for HOXD13 and the sharing of the 
same role for other HOX proteins was hypothesized. In the case of HOXD13, this 
activity seems to be regulated by Geminin, that blocks the stimulation of origin 
licensing mediated by HOX protein. Furthermore, it was observed that the binding of 
Geminin interferes with the binding of HOXD13 and a pre-RC protein Cdc6, 
controlling also in this way the activity at replication origins149. A model proposed for 
the involvement of HOX in DNA replication is that increasing levels of Geminin would 
be sequester both HOX proteins and Cdt1, thereby blocking reinitiation of DNA 
replication, induced by HOX proteins and Cdt1, until Geminin becomes inactivated 
during mitosis. 
HOX transcription factors appear in fact to possess adequate properties for the 
regulation of replication initiation at multiple origins given that they present a low 










































2.1. Characterization of polyclonal anti-HOXC13 antibody 
 
The human recombinant HOXC13 protein fused to GST was obtained by cloning 
of aminoterminal portion of HOXC13 encompassing amino acids 1 to 259 in pGEX 2T 
(Amersham Biosciences) vector. This fusion protein exclude the highly conserved 
homeodomain of HOXC13 (amino acids 260 to 319) in order to obtained more specific 
antibodies against this HOX protein. The recombinant GST tagged HOXC13 protein 
was produced in E. coli BL21 strain and purified by reduced glutathione agarose 
(Sigma) beads. The purified protein was then used for polyclonal rabbit antibodies 
production.  
Two rabbits (A and B) were injected with the purified GST-HOXC13 protein 
following the standard ICGEB immunization protocol. A series of 5 injections and 
bleedings were obtained from each rabbit and kept separately. Sera were then purified 
by IgG purification kit (Viva Science) and tested for specific recognition of recombinant 
HOXC13 used as antigen, and for recognition of endogenous protein in nuclear extracts 
from human cells. Nuclear extracts from HeLa cells were run in linear gradient gels. 
These are polyacrylamide gels having a gradient of increasing acrylamide 
concentrations and linearly decreasing pore size. These gels have the advantages over 
SDS-PAGE linear gels, with fixed concentration because a much greater range of 
protein molecular weight values can be separated on a gradient gel than on a fixed-
concentration gel. Moreover, using this kind of gels, there is a greater likelihood of 
resolving proteins with very similar molecular weight values than on fixed-
concentration gels. 
We set the conditions for the Western blot analyses and we choose the sera 
derived from the immunization of the rabbit B, because it displays a greater efficiency 
in recognize the protein and the observed band appear at the expected molecular weight 


























Figure 1.1. Identification of HOXC13 protein in human cells by immunoblotting. Western 
blot assays were performed with nuclear extracts from asynchronous HeLa cells. Extracts were run in a 
gradient gel and after blotting, the detection of HOXC13 was performed with sera from different rabbits. 
7A and 7B indicate the sera from the last bleeding (7) of the rabbit A and rabbit B respectively. Only the 
sera from rabbit B recognized a band at the expected molecular weight for HOXC13, about 35 KDa. 
 
 
2.1.1. Western blot detection of endogenous and double tagged HOXC13 in 
cells extracts 
 
We also produced HeLa and T98G stable clones expressing a double-tagged 
version of full length HOXC13. The cDNA of HOXC13 was cloned into pFHIRES Neo 
vector and transfected in HeLa and T98G cells lines. This vector contains the Neo 
resistance gene for positive selection with G418 drug of transfected cells and expresses 
a N-terminal Flag-HA double-tagged fusion protein. The transfected cells were selected 
on G418 containing medium for more that two weeks to obtained a stably transfected 
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pool of cells. The expression of the double-tagged Flag-HA HOXC13 in stable cell lines 
was detected using the anti-HA and/or anti-Flag antibodies. Those antibodies recognise 
a band at about 45 KDa corresponding to the recombinant protein. We used total cell 
extracts to further confirm the specificity of polyclonal antibodies against HOXC13. As 
shown in figure 1.2, in extracts from clones expressing the double-tagged recombinant 
protein, HOXC13 was similarly detected by anti-HA and anti-Flag antibodies as a clear 
band migrating of 42 KDa above the endogenous one, and corresponding to the 
additional band of same molecular weight detected by the specific antibody against 
















Figure 1.2. Characterization of purified polyclonal antibody against HOXC13. T98G cell line 
and T98G clone expressing HA-Flag-HOXC13 were used to check the ability of our antibody to 
recognize endogenous and recombinant HOXC13. 
 
 
2.1.2. Partial proteolytic peptide maps 
 
To further confirm the specificity of our antibody against the HOXC13 protein, 
we utilized a peptide mapping approach. In this assay, the treatment of two identical 
protein samples with a specific protease but at different concentration, will generate a 
series of products ranging in size from fully digested to undigested protein. When the 
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products of these individual reactions are run side by side on lanes of one-dimensional 
SDS-polyacrilamide gel, a ladder of digestion products is displayed that gives a 
diagnostic fingerprint of the polypeptide backbone. When two proteins are identical, 
these partial proteolytic maps can be used to confirm their identity. Even a minor 
changes in the polypeptide is enough to produce a vastly different pattern.  
We compared the fingerprint obtained after trypsin digestion on purified HOXC13 
protein and total cell extract. To prepare the samples for enzyme digestion, purified 
HOXC13 and total extract were run in a SDS-polyacrilamide gel that was then stained 
with Coomassie and dried on paper to excise the different bands. The HOXC13 band 
was the substrate for digestion with a fixed concentration of trypsin. After digestion 
were observed a clear fingerprint proteolytic profile for HOXC13. So, we treated the 
dried gel slices corresponding to molecular weight corresponding to HOXC13 in T98G 
total cell extract and, as negative control, we used a gel slices of the same lane of total 
cell extract that do not corresponds to HOXC13 molecular weight. The digestion occurs 
directly inside the wells of a modified polyacrilamide gel and then the gel is run to 
separate the different proteolytic products. 
By a western blot analysis using the specific antibody against HOXC13, we 
compared the fingerprint obtained from the recombinant purified HOXC13 and total 
cellular extract digestions. As shown in figure 1.3, the peptide fingerprint detected by 
HOXC13 antibody in total cell extract is very similar to the digested recombinant 
HOXC13 protein, and this antibody did not recognize any proteins in the lane of the 
negative control, as expected. This result indicates in this way that the HOXC13 band 
protein recognized in cell extracts by our antibody specifically correspond to the 

















Figure 1.3. Western blot analyses of the proteolytic products produced after enzymatic 
digestion of T98G cells (TOT ex) and negative control (Neg ctr) cell extracts, and recombinant 
HOXC13 (HOXC13) protein by HOXC13 antibodies. The comparison of the detected bands in both 
samples demonstrates that HOXC13 antibody specifically recognizes the full-length protein and its 
proteolytic fragments in both cell extracts and purified recombinant protein digestions.  
 
 
2.1.3. Immunoprecipitation of tagged HOXC13  
 
To test the ability of our antibody to specifically immunoprecipitate HOXC13, we 
performed an immunoprecipitation (IP) using total cell extracts from HeLa stable clone 
expressing double-tagged Flag-HA HOXC13. The expression of the double tagged 
Flag-HA protein was monitored using the anti-HA and anti-Flag antibodies. In this way, 
we could detect the immunoprecipitated HOXC13 also by other antibodies specifically 
recognizing the tags of the fusion protein. The immunoprecipitation assays were 
performed using the antibody against HOXC13, while immunoblots were revealed 
using an antibody against HA tag. As shown in figure 1.4, a clear signal at the expected 
molecular weight for the recombinant protein, about 45 KDa -10 KDa more that the size 
of the protein due to the tags- was found in the HOXC13 IP lane, demonstrating that our 
antibody specifically immonuprecipitates HOXC13. As controls, we used the specific 
antibody in only IP buffer (without cell extract) to exclude those bands corresponding to 
the light and heavy chains of the antibody after IP; the IgG in the cellular extract as 
negative IP control and a protein tagged with HA (HA-GCN5) as positive immunoblot 













Figure 1.4. Immunoprecipitation of tagged HOXC13. Total cell extracts from HeLa stable 
clone expressing double-tagged Flag-HA HOXC13 were used for immunoprecipitation experiments. 
Anti-HA antibody detects a specific tagged HOXC13 after immunoprecipitation with the specific 
antibody against HOXC13 (HOXC13) corresponding to the same band detected in the input lane. This 
band was absent in the IP using the antibody alone (Buff) and in the IP with IgG used as negative control. 
The tagged protein was also detected in the flow through (FT) recovered after the immunoprecipitation. A 




2.2. Expression of HOXC13 in different human cell lines 
 
Homeotic genes are principally involved in the specification and regulation of the 
patterns of development of the body. To carry out this function, their expression is 
modulated in a tissue-specific manner. We analysed the expression of HOXC13 in cell 
lines by Western blot analysis of total extracts from different cell types. As shown in 
figure 2, the cell lines analysed were: the U2OS cell line, with epithelial morphology, 
derived from the bone tissue of a fifteen-year-old human female suffering from 
osteosarcoma; SAOS cells, a non-transformed cell line from sarcoma osteogenic, 
derived from the primary osteosarcoma; the T98G glioblastoma cells, derived from a 
glioblastoma multiforme; 293T derived from the transformation of normal human 
embryonic kidney cells with adenovirus; the spontaneously transformed human 
epithelial HaCat cell line derived from adult skin, which maintains full epidermal 
differentiation capacity and are immortal but non-tumorigenic; the HeLa cell line, 
derived from cervical cancer cells and the U937 monocytic cells, isolated from the 
histiocytic lymphoma.  
 57
Immunoblot analysis in these different cell types showed that in some cases, like 
for 293T and U937, the expression of HOXC13 protein were not detectable, at least by 
immunoblot, as showed in figure 2. In these cell extracts no appreciable bands were 
detectable at the expected molecular weight, indicating absence or low expression levels 
of this protein. The bigger expression of HOXC13 was observed in HaCat cells and 
















Figure 2. Expression levels of HOXC13 protein in different human cell lines. Western blot 
analyses of the total extract from the indicated cell lines were performed using antibody against HOXC13 
to detect the levels of protein expression. To control the amount of total extract loaded in the gel, the 
levels of alpha tubulin were detected by antibody against tubulin (α tubulin). 
 
 
2.3. Protein expression of HOXC13 throughout the cell cycle 
 
The expression levels of HOXC13 protein were analysed during the cell cycle by 
Western blot using our antibody against HOXC13, in total extracts of synchronized 
HeLa and T98G cells. 
First we synchronized HeLa cells by sequential treatment with thymidine and 
nocodazole, where the last a drug inhibits microtubule polymerization and arrests cells 
in G2/M phases. These cells were then harvest by shake-off, released from the block by 
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several washes, replated into new cell plates and harvest at different times. At 5, 10 and 
15 h from the release, harvested cells correspond to early G1, G1/S transition and S 
phase cell population, respectively. 
A second cell line T98G was chosen to analysed the expression levels of 
HOXC13 during the cell cycle. T98G cells are characterized by their high HOXC13 
expression and their capability to be synchronized in G0 phase (quiescent state) by 
serum deprivation. T98G cells were synchronized by serum starvation method, first 
growing cells in completed medium for 24h and then for 72h in medium without growth 
factors (serum). This longer incubation blocks all cells in quiescent phase. The cells are 
then released from the G0 state by serum addition to the medium and then cells re-enter 
in the cell cycle all together. Upon re-addition of serum, cells synchronously progressed 
throughout G1 and S phases. Thus, the synchronized cells can be collected at different 
times, coinciding with different phases of the cell cycle of our interest. 
The advantage of serum starvation method for cell synchronization is the 
possibility to avoid the use of drugs, but one limit of this method is that  over the 28h 
after the release cells loose synchronicity after they rised G2 phase and only a portion of 
the entire population result to be in the expected next phase. So we used nocodazole 
drug to block the cells in G2/M phases, corresponding to the collection 32h after the 
initial release.  
Cell synchronizations showed that contrary to what was observed for another 
HOX protein involved in DNA replication, HOXC10, which levels are reduced in early 
G1 phase, increased during the cell cycle until the G2 and became undetectable in M 
phase, the levels of HOXC13 are constant throughout the cell cycle in both cell lines. 
As shown in figure 3.1 and 3.2, the HOXC13 protein abundance detected in HeLa and 
in T98G cells, compared with tubulin abundance used as internal loading control, 
clearly showed that HOXC13 does not changes through the cell cycle. 
The goodness of cell synchronization profiles of propidium iodide stained cells 
was observed by the FACS analysis, using a similar fraction of the cells collected and 
used for immunoblotting analysis (figures 3.1 and 3.2). We also confirmed cell 
synchronization profiling by immunoblotting using specific antibodies against cyclin A, 




























Figure 3.1. HOXC13 expression levels through the cell cycle in HeLa cells. The upper panel 
shows the experimental scheme used for cells synchronization. HeLa cells were synchronized in G2/M by 
a double thymidine/nocodazole block, and then release from the block to obtain cells in G1, G1/S and S 
phase. The total lysates corresponding to each cell population were analysed by immunoblotting with the 
tubulin and HOXC13 antibodies. In the lower panel, flow cytometry profiles of asynchronous cells (As), 



































Figure 3.2. HOXC13 expression levels through the cell cycle in T98G cells. The upper panel 
shows the experimental scheme for T98G cells synchronization. T98G cells were synchronized by serum 
starvation in G0, and release at different time point after serum starvation, and by nocodazole treatment to 
obtain the G2/M phase. The total lysates corresponding to each cell population were analysed by 
immunoblotting with the indicated antibodies. In the lower panel are shown the flow cytometry profiles 
of propidium iodide stained cells blocked in G0 by serum starvation (0 hr), cells at different times after 


















Figure 3.3. Cyclin A expression levels in synchronized T98G cells. The upper panel shows a 
draw indicating the classical profile of expression of cyclins throughout the cell cycle. The lower panel 
shows the immunoblotting of the same cell extracts used for analysis of HOXC13 expression in T98G 
cells. Levels of cyclin A expression were analysed in different stages of the cell cycle by western blot. 
 
 
2.4. Interactions of HOXC13 with other replication protein complexes  
 
To understand the direct involvement of HOXC13 with DNA replication, we first 
investigate the affinity of this protein for different components of the pre-RC by GST 
pulldown experiments. In vitro translated [35S]-labeled Cdc6, ORC1, MCM2 and 
MCM3 were challenged for their ability to bind a GST-HOXC13 fusion protein. Figure 
4.1 shows that Cdc6 and ORC1 were specifically retained on GST-HOXC13 agarose 
beads but not on GST beads used as control, indicating a direct interaction between 
HOXC13 with Cdc6 and ORC1, two proteins that specifically bind to DNA replication 
origins; differently, MCM2 and MCM3, two members of the MCM helicases complex, 
were not retained upon in vitro binding, suggesting an absence of direct interaction of 
this factors with HOXC13. To control the amount and integrity of the GST fusion 
proteins on agarose beads used for each assay upon in vitro binding, gels were stained 
with Coomassie reagent before autoradiography.  
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A more detailed analysis of the interacting moieties of HOXC13 and Cdc6 was 
carried out, as reported in figure 4.2. To determine which portion of Cdc6 interacts with 
HOXC13, two Cdc6 fragments, showed in the figure 4.3, one from the aminoterminal to 
aminoacid 363 and the other from aminoacid 364 to the carboxyterminal, were 
immobilized on the beads and challenged with full-length [35S]-HOXC13. Neither of 
Cdc6 fragments tested was able to interact with HOXC13, indicating that the central 
portion integrity of Cdc6 is likely to be the interacting moiety. Conversely, using the in 
vitro translated [35S]-labeled Cdc6 for in vitro binding with N-terminal and C-terminal 
HOXC13 fragments as GST fusion proteins, we only observed a clear interaction only 
with the C-terminal portion of HOXC13, that encompasses the homeodomain, 
indicating this moiety as important for Cdc6 interaction. 
The same type of in vitro assays were used to test HOXC10 as interacting proteins 
with pre-RC protein components. This HOXC10 homeotic protein was identified 
together with HOXC13 for its ability to bind the lamin B2 origin in the one hybrid 
screening assay. Surprisingly HOXC10 was unable to bind Cdc6 in GST pulldown 
assay, thus suggesting that interaction observed between HOXC13 and Cdc6 was 
specific (figure 4.4). 
This specific interaction was also confirmed by co-immunoprecipitation 
experiment performed in asynchronous T98G. The cells were first crosslinked by 
formaldehyde and the total cell extracts were then used for immunoprecipitation with 
specific antibodies against Cdc6. The immunoprecipitated material was separately 
divided, one part was used for immunoblotting with antibodies against Cdc6 and the 
other for HOXC13 immunoblotting to check the presence of both the proteins in the 
samples.  
Hence, as shown in figure 4.5, HOXC13 was co-immunoprecipitated after Cdc6 
immunoprecipitation  
We can conclude that HOXC13 displayed a significant in vitro affinity for two 
members of the pre-RC, ORC1 and Cdc6. Additionally we showed that this interaction 
























Figure 4.1. HOXC13 binds Cdc6 and ORC1 in vitro. GST or GST-HOXC13, immobilized on 
agarose beads were incubated with in vitro translated [35S]-labeled MCM2, Cdc6, MCM3, and ORC1. 
Proteins retained by extensively washed beads were loaded onto a 10% acrylamide-SDS gel and the gel 
exposed to Cyclone screen. The input lanes contain a fraction of the radiolabeled proteins prior to binding 
(IN). Graphs show the amount of bound radiolabeled proteins as % of the input. On the right of each 




































Figure 4.2. HOXC13 interacts by its homeodomein with Cdc6. In the upper panel, [35S]-labeled 
HOXC13 was incubated with GST, GST-Cdc6 full length, GST-Cdc6 aminoterminal or GST-Cdc6 
carboxyterminal and processed as described above. In the lower panel, [35S]-labeled Cdc6 was incubated 
with GST-HOXC13 full length, GST-HOXC13 aminoterminal, GST-HOXC13 carboxyterminal or GST, 
and processed as already described. The input lanes contain a fraction of the radiolabeled proteins prior to 
binding (IN). Graphs show the amount of bound radiolabeled proteins as % of the input. On the right of 















Figure 4.3. Representative scheme of Cdc6 and HOXC13 aminoacidic domains used in the GST 















Figure 4.4. HOXC10 does not interact with Cdc6 in vitro. GST or GST-HOXC10, immobilized 
on agarose beads were incubated with in vitro translated [35S]-labeled Cdc6 and processed as described 
above. The input lanes contain a fraction of the radiolabeled proteins prior to binding (IN). Graphs show 
the amount of bound radiolabeled proteins as % of the input. On the right of each autoradiography, 

















Figure 4.5. HOXC13 binds Cdc6 in vivo. Extracts of T98G (Input) cells were 
immunoprecipitated with antibodies against Cdc6 (IP Cdc6), IgG (IP IgG) and antibodies against 
USF1(IP USF1) as controls. The immunoprecipitated material was divided for separately western blotting 
analysis and revealed with antibodies against Cdc6 and HOXC13. 
 
 
2.5. Binding of HOXC13 to lamin B2 origin  
 
HOXC13 was identified in a one hybrid screening assay for its ability to 
specifically interact with the human lamin B2 origin. This interaction was confirmed in 
vitro by electrophoretic mobility shift assay (EMSA) and by immunological detection 
on origin DNA on agarose beads, and in cell milieu by CAT assay145, 148. We want to 
answer the question whether this protein is actually bound in vivo to this origin. In order 
to investigate this possibility we used the technique of chromatin immunoprecipitation 
(ChIP) in asynchronous cultures of the human glioblastoma T98G cell line, in which 
HOXC13 is abundantly expressed and this origin is fully functional, as previously 
shown by our group. 
The cells were treated with 1% formaldehyde and the extracted DNA cross-linked 
protein material was chopped with subsequent micrococcal nuclease digestion and 
sonicated to a DNA fragment size ranging from a maximum of 1000 bp to a minimum 
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of about 160 bp, approximately corresponding to a nucleosome. The cross-linked and 
shared chromatin was then immunoprecipitated with our specific antibodies against 
HOXC13. These antibodies only recognize the N-terminal portion of the protein. This 
characteristic was essential to increase its specificity for the target protein and avoid 
interference with the DNA-recognition sequences that are mediated by the 
homeodomain of HOXC13. We analysed the immunoprecipitated HOXC13 by western 
blot analyses as shown in figure 5.1, and then we decross-linked DNA from the 
immunoprecipitated material. The resulted DNA was then quantitatively assayed by 
competitive PCR to determine the presence of lamin B2 origin and origin-unrelated 
sequences by B48 and  B13 probes respectively150. As shown in figure 5.2, the 
immunoprecipitated DNA is significantly enriched in origin sequences relative to 
origin-unrelated DNA, demonstrating that HOXC13 protein is bound to the lamin B2 
origin in dividing cells. The USF1 transcription factor, known to be constantly present 
on the promoter located upstream of the TIMM13 and downstream the lamin B2 gene, 
resulted also enriched and bound to the origin area, as expected The relatively lower 
degree of enrichment, besides the possible lesser efficiency of the antibody, may be due 
to the relatively small size of the DNA fragments, considering that the USF1 binds 
approximately 260 bp away from the start site and approximately 50 bp to the right of 
the border of the pre-replicative complex.  
Since we found HOXC13 bound to lamin B2 origin in dividing cells, we wonder 
if its presence is connected or not with the DNA replication, thus we analysed whether 
HOXC13 is also bound to the origins in non-cycling T98G cells arrested in G0 phase by 
serum starvation. In this context, the USF1 factor was found bound to the downstream 
promoter close to the lamin B2 origin, whereas the HOXC13 protein results to be 
completely absent on the same origin in quiescent cells (figure 5.2), in agreement with 
the known absence of replicative complexes on the origin in these conditions. This is 
not due to an absence of the protein in non-cycling cells, because these contain the same 
level of the protein as the cycling ones, as previously shown.  
Hence, not only the binding of HOXC13 with the lamin B2 replication origin, but 

























Figure 5.1. Immunoprecipitation of endogenous HOXC13. Immunoprecipitation experiments 
were performed with lysates from asynchronous crosslinked T98G cells (Input) using the specific 
antibody for HOXC13 and immunoglobulin (IgG) as control. The immunoblot analyses were performed 






































Figure 5.2.  Binding of HOXC13 and USF1 proteins to the lamin B2 origin. ChIP analysis was 
performed on cross-linked chromatin from T98G cells and immunoprecipitated with the indicated 
antibodies. The immunoprecipitated DNA was then quantitatively assayed by competitive PCR to 
determine the presence of lamin B2 origin and origin-unrelated sequences by B48 and B13 probes, 
respectively. The histograms report the relative enrichment of B48 sequences over the B13 ones in the 
different immunoprecipitates, as derived from the analysis of the PCR reactions shown in parallel. The 
enrichment values obtained by a pre-immune serum control are also shown. Upper panel: results in 
asynchronously growing cells; bottom panel: cells starved in G0. 
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2.5.1. Cell cycle dependent binding of HOXC13 to lamin B2 
 
Next, we asked whether HOXC13 binding to lamin B2 origin occur in a cell cycle 
dependent fashion, as expect for an interaction related with the origin function. For this 
purpose, a more precise and efficient cell synchronization in all phase of the cell cycle 
was used. T98G cells were synchronized by serum starvation and drugs. Then cells 
were tested for the binding of HOXC13 to the origin by ChIP assays, as already 
described. Competitive PCR analysis was used to measure the enrichment in the lamin 
B2 origin sequences in the precipitated DNA. 
The G1 cells were achieved by the release of G0 cells from serum starvation. Late 
G1 cells were obtained by mimosine treatment, G1/S border and the S phases  arrested 
cells were obtained by release from mimosine block. While G2/M arrested cells were 
obtained by sequential treatment with thymidine and nocodazole drugs.  
As shown in the graph in the figure 5.3, HOXC13 appears bound to the origin 
region at the beginning of G1 and reaches a peak value at the G1/S transition, indicating 
that HOXC13 binding to the lamin B2 origin mostly occurs in G1 phase. As the cells 
enter into S phase, HOXC13 leaves the origin and then returns to it only at the next G1 
phase.  
Our data clearly demonstrate that HOXC13 binds to lamin B2 origin in a cell 
cycle dependent manner and its maximal binding occurs at the G1/S border, consistent 
with the time of origin activation expecting for an early firing replication origin like 
lamin B2. Therefore, this observation clearly suggests a direct involvement of HOXC13 





























Figure 5.3. Temporal binding of HOXC13 to the lamin B2 origin by ChiP analysis. The 
histograms reported in the upper panel show the relative enrichment of B48 sequences over the B13 ones 
in the different cell populations. The relative enrichment reported in the histograms derived from the 
analyses of competitive PCR reactions showed in the bottom panel. The line in the graph indicates the 
threshold enrichment level obtained by using rabbit IgG antibody as negative control. Cell 
synchronizations were confirmed by FACS analyses using a portion of the cells from the synchronized 






2.5.2. Analysis of the lamin B2 origin structure by footprinting assay  
 
In order to confirm a direct interaction of HOXC13 with lamin B2 origin DNA, 
we utilized a combination of ChIP and in vitro DMS footprinting assay. The position of 
HOXC13 was explored in more detail by this fine technique, modifying the cross-
linked, immuno-purified DNA to dimethyl sulfate (DMS) and analysing the produced 
fragments after degradation by ligation-mediated PCR (LM-PCR) technique. A clear 
footprint was observed (figure 5.4.) on the lower strand within nucleotides 3910 and 
3990, corresponding to the area protected by the pre-RC in G1151. This area includes 
also the sequence recognized in vitro by HOXC13145. The large protection observed in 
Figure 4B is certainly not due exclusively to this molecule, in fact the formaldehyde 
treatment produces also protein-protein cross-links and the footprint is most probably 
due to the covalent linking of several RC members, including HOXC13. Also, the 
quantitative variations in the course of G1 may in part reflect a greater exposure of 
HOXC13 epitopes as the RC evolves rather than an actual increase in amount of bound 
protein. 
We can conclude that HOXC13 assembles in G1 together with the other pre-RC 
molecules on the origin and leaves it after firing. This suggests that HOXC13 must 




































Figure 5.4. Analysis of in vivo HOXC13 interaction with the lamin B2 origin by a 
combination of ChIP and DMS footprinting. Footprint was obtained using in vivo cross-linked and 
sonicated chromatin. Chromatin was immunoprecipitated with anti-HOXC13 antibody and the resulting 
DNA-proteins complexes were subjected to footprint analysis by dimethyl sulfate (DMS) treatment and 
followed by ligation-mediate PCR (LM-PCR) of the produced fragments. DMS treated genomic DNA 
was used as control ladder for LM-PCR. In the figure, the bars indicate the covered area due to the 
binding of the prereplication complex in G1 phase in vivo (red) and in vitro (yellow) and the covered area 
due to the binding of HOXC13 in asynchronous growing HeLa cells (green). 
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2.6. Interaction of HOXC13 with other origins. 
 
We showed that HOXC13 protein interacts with the lamin B2 origin and seems to 
be involved in origin function. Furthermore, HOXC13 interacts with two crucial 
proteins of the pre-RC complex, Cdc6 and ORC1, required for replication origin activity 
and involved in recognition and binding to replication origin sequences. Therefore, we 
asked at this point whether HOXC13 interaction is peculiar only for this origin or it is 
also present in other human replication origins, and whether those interactions are also 
linked to the proliferative state of the cells. 
We probed two other replication origins identified in the recent years in the 
human genome, represented by the TOP1 origin, localized in the GpC island upstream 
the human TOP1 gene on chromosome 2049, and MCM4 origin located in the genomic 
region close to or overlapping with the genetic control elements of the divergently 
transcribed genes MCM4 and PRKDC152, that are both active in T98G cells.  
Chromatin immunoprecipitation assays were performed on T98G cell line as 
previously described. As shown in figure 6, the resulted DNA was analysed by 
multiplex PCR using primers able to equally amplify the two origin sequences and the 
non-origin B13 sequence, contemporaneously. The PCR amplifications were performed 
on genomic DNA isolated from quiescent G0 cells (lanes of set A), on DNA derived 
from cross-linked chromatin isolated from G0 cells (set B), both synchronized by serum 
starvation, on DNA derived from cross-linked chromatin isolated from the same cells as 
set B but after immuno-precipitation with anti-HOXC13 antibody (set C), on DNA 
derived from cross-liked chromatin derived from asynchronously growing cells (set D), 
and on DNA derived from the same cells as Set D but after immuno-precipitation with 
anti-HOXC13 antibody (set E). The results show that each DNA sample of sets A, B, C 
and D contains, using previously established conditions, comparable amounts of the 
three probed sequences, also after the DNA treatment required for ChIP assay, whereas 
the sequences corresponding to the two origins are significantly enriched with respect to 
the B13 control following immuno-precipitation of the asynchronously growing cells 
(set E). Thus, we demonstrate that the HOXC13 protein interacts also with the human 
replication origins located TOP1 and MCM4, but only when the cells are cycling and 
not resting in quiescent G0 phase, according with the presence of the replicative 
complex on the origins in replicating cells. 
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This observation tends to downplay the possible role of this molecule as a 
sequence-specific transcription factor in the context of origin function. In fact, HOX 
proteins display a rather loose specificity for the DNA sequence bound, and moreover, 
the MCM4 and TOP1 origins do not display any similarity to the lamin B2 origin 
sequence, and, in particular, do not contain the tract of this sequence recognized in vitro 
by the HOXC13 molecule145.   
To further check the loading of HOXC13 preferentially on early firing origins to 
which all the three tested origins belong rather that late one, we analysed the binding of 
this protein with the late firing origin β-globin.  
ChIP analyse was performed on asynchronous growing T98G cells and the 
resulted DNA was analysed by PCR performed using, in the same PCR reaction, 
primers able to equally amplify the β-globin origin sequences and the non-origin B13 
sequence. By the comparison between the amplification products from cross-liked 
chromatin derived from asynchronously growing cells and the DNA derived from the 
same cells but after immuno-precipitation with anti-HOXC13 antibody, we found that 
after immuno-precipitation the sequence corresponding to the origin is not significantly 
enriched with respect to the B13 control, indicating that HOXC13 does not bind the late 
firing origin β-globin. 
We conclude that the presence of HOXC13 on replication origins appear to be a 
common feature exclusively of the human early replicating origins, that also represent 































Figure 6.1. Binding of HOXC13 to TOP1 and MCM4 origins. The relative abundance of 
sequences corresponding to the TOP1 origin, to the MCM4 origin and to the B13 non-origin control was 
evaluated by probing the extracted DNA with sets of three serial two-fold dilutions of the samples, 
amplified through 35 PCR cycles using specific primers for the three sequences153. Set A: control DNA 
extracted from T98G cells in G0. Set B: DNA extracted from formaldehyde cross-linked T98G cells in 
G0. Set C: DNA extracted from formaldehyde cross-linked T98G cells in G0, after immuno-precipitation 
with anti-HOXC13 antibody. Set D: DNA extracted from asynchronously growing, formaldehyde cross-
linked T98G cells.  Set E: DNA extracted from asynchronously growing, formaldehyde cross-linked cells 

























Figure 6.2. Binding of HOXC13 to the beta globin orgin. The relative abundance of sequences 
corresponding to the beta globin origin, and to the B13 non-origin control was evaluated by probing the 
extracted DNA with sets of three serial two-fold dilutions of the samples, amplified through 35 PCR 
cycles using specific primers for the two sequences153. Set A: control DNA extracted from T98G cells in 
G0. Set B: DNA extracted from asynchronously growing, formaldehyde cross-linked T98G cells.  Set C: 
DNA extracted from asynchronously growing, formaldehyde cross-linked cells after immuno-
precipitation with anti-HOXC13 antibody. 
 
 
2.6.1. Cell cycle dependent binding of HOXC13 to TOP1 and MCM4 
 
As for the lamin B2 origin, after the observation of the binding between HOXC13 
and the two origins TOP1 and MCM4 occurred exclusively in replicating cells, we 
asked whether these binding change in relation with cell cycle progression. Chromatin 
immunoprecipitation assays were performed on T98G cell line synchronized by the 
same protocols previously described. As shown in figure 6.2, the resulted DNA was 
analysed by multiplex PCR as above. 
The amplification was performed on genomic DNA isolated from quiescent G0 
cells (lanes of set A), on DNA derived from cross-linked chromatin isolated from 
different phases of the cell cycle (lanes of set B), on DNA derived from cross-linked 
chromatin isolated from the same cells as set B but after immuno-precipitation with 
anti-HOXC13 antibody (set C). The results show that each DNA sample of sets A and B 
contains, using the same established conditions, comparable amounts of the three 
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probed sequences, and also the sequences corresponding to the two origins are not 
enriched with respect to the B13 control following immunoprecipitation in all the 
phases, except in G1/S border, where it was observed an enrichment of the DNA 
corresponding to TOP1 origin (set C). Thus, we demonstrate that the HOXC13 protein 
interacts with the human replication origins TOP1 in G1/S border, the same moment in 
which it bound the lamin B2.  
About the MCM4 origin, it is not clear by this methods and using these time of 




















Figure 6.2. Binding of HOXC13 protein on the two origins TOP1 and MCM4 during the cell 
cycle. The relative abundance of sequences corresponding to the TOP1 origin, to the MCM4 origin and to 
the B13 non-origin control was evaluated by probing the extracted DNA with sets of three serial two-fold 
dilutions of the samples, amplified through 35 PCR cycles using specific primers for the three 
sequences153. Set A: control DNA extracted from T98G cells in G0. Set B: DNA extracted from 
formaldehyde cross-linked T98G cells in different phase of the cell cycle, indicated on the right of each 
panel. Set C: DNA extracted from formaldehyde cross-linked T98G cells in synchronized cells, after 
immuno-precipitation with anti-HOXC13 antibody. 
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2.7. UV-photofootprinting of origin structure 
 
In eukaryotic cells the DNA replication origins are not defined by a single 
consensus sequence, as observed for budding yeast, but many features other than 
sequences seem to participate in the definition of a region as replication starting site. 
Also in the case of HOXC13 in fact, we observed a binding to replication origins that 
does not depend on DNA sequence, since the three analysed origins have not sequence 
similarity. Hence, other elements have to be involved in the binding of HOXC13 with 
the origins, like the chromatin structure, that in general is indicated as a factor 
influencing the chosen of the sequence as replication origin. 
In order to investigate the role of DNA topology in origins specification, we 
analysed the impact of the disruption of chromatin organization at the origin sequence, 
inducing histone hyperacetylation by treating cells with trichostatin A (TSA), an 
inhibitor of histone deacetylase. The disturbance caused by TSA reduces origin activity 
of the lamin B2 origin of at least fifty per cent, as demonstrated by our group and also 
previously reported71.  
We applied the UV photofootprinting technique coupled with TD-PCR in 
synchronized cells. This technique is able to detect topological changes at or around the 
site of association of proteins with DNA. The UV irradiation causes pyrimidine dimer 
formation but the binding of proteins to DNA or changes in DNA flexibility block the 
induction of these dimer. In this way we can detect the topological DNA changes, 
induced by TSA treatment, at or around a site of association with proteins and 
furthermore this detection can be done directly in native cells. 
HeLa cells were synchronized in M, G1 and S phases of the cell cycle and treated 
with TSA 100ng/ml for 1h and 4h. In this way we can analyze not only the topological 
changes happening in different phase of cell cycle, but also the influence of TSA in 
specific phase of cell cycle. For cell synchronization were used nocodazole in order to 
obtain M phase cells, a drug which inhibits microtubule polymerization, aphidicolin for 
G1/S border - early S cells, a DNA polymerase inhibitor, while middle of G1 cells were 
obtained replating M cells in complete medium for 5 hours. Hence, DNA was isolated 
after UV irradiation from synchronized HeLa cells without treatment or with 1h or 4h of 
TSA treatment. The DNA was subjected to TD-PCR with primers probing the upper and 
the lower strand. The region probed corresponds to the sequence covered by the 
replicative complexes of the lamin B2 origin. Figure 7.1 shows results obtained with 
specific primers, in different phase of cell cycle, with or without TSA. We measured, 
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using the image J program, the intensity of the bands visualized by autoradiography. 
The increasing in the intensity of the bands suggest that the TSA treatment induced 
modifications in DNA topology and revealed a dynamic variations of the protein-DNA 
interactions. We found that TSA treatment modifies significantly the pattern observed at 
the different moments of the cell cycle, particularly at the region around and at the start 
site. We can conclude that the TSA treatment induced modification in DNA topology in 





















Figure 7.1. Photofootprinting analyses of a region encompassing the lamin B2 origin area in 
synchronized HeLa cells treated or not treated with TSA. The yellow and red bars indicate the 
covered regions in the G1 and S phases of the cell cycle. The TSA treatment was made for 1 and 4 hours. 
M, midG1 and early S are the phase of the cell cycle in which the cells were synchronized. After the UV 
irradiation, the DNA from these cells was subject to TD-PCR whit primers probing the upper and the 
lower strand (not shown). The intensity of the bands were analysed by Image J program and the resulted 




2.7.1. Effects of disruption of origin chromatin 
 
At this point we wonder if in addition to the showed reduction in the origin 
functionality and the observed modification in DNA topology, other effects could be 
detected in parallel on the replication origins after TSA treatment. Thus, we analysed 
the effects of the incubation with TSA on the ability of the origin area to bind some 
members of replicative complex and we found that this was reduced. In fact, by ChIP 
assay on T98G cells treated with TSA before the crosslink with formaldhyde, using 
antibody against Cdc6 and HOXC13, we observed a loss of binding between both, Cdc6 
and HOXC13, with lamin B2 origin, a binding that indeed we observed without TSA 
treatment. Thus, as shown in figure 7.2, Cdc6 and its partner HOXC13 cannot bind the 
origin as a consequence of TSA treatment. 
The TSA-induced disturbance in HOXC13 binding to the origin is observed also 
for the TOP1 and MCM4 origins that shown to be bound by HOXC13. Figure 7.3 
reports the results of PCR performed using, in the same PCR reaction, primers able to 
equally amplify the two origin sequences and the non-origin B13 sequence, as already 
described for the identification of the binding between HOXC13 and the two origins 
TOP1 and MCM4. The comparison of the PCR products of set B (non-immuno-
precipitated chromatin of cycling cells) and set C (the same, in presence of TSA) shows 
that the abundance of the three sequences, two corresponding to the origin sequences 
and the non-origin control B13, is not significantly changed; conversely, in the samples 
immunoprecipitated with anti-HOXC13 antibody, the ones obtained from TSA-treated 
cells (set E) lose the enrichment in origin sequences present in the non-treated ones (set 
D). Thus, an appropriate chromatin organization of the origin area appears to be 
required for the formation of an active replication complex. Notably, chromatin 
disruption does not affect other different protein-DNA interactions even if occurring in 
close proximity, but not involved in the prereplication complex formation. In fact, the 
binding of the USF1 transcription factor to the nearby promoter for the TIMM gene147 is 
unaffected by chromatin disruption, as shown in figure 7.2. 
we conclude that the structural features of chromatin at the origins appear to play 
an important role in origin function also through the modification of proteins binding, 































Figure 7.2. Comparison of ChIP performed without and with TSA treatment. The histograms 
report the relative enrichment of the B48 sequence over the B13 one in the different immunoprecipitates, 
as derived from the analysis of the competitive PCR reactions, using HOXC13 antibody (upper graphs) or 
Cdc6 antibody (bottom graphs). For each ChIP experiment USF1 and rabbit IgG were used as positive 

















Figure 7.3.  Association of HOXC13 with TOP1 and MCM4 origins in vivo. PCR was 
performed on genomic DNA isolated from quiescent cells (G0), on chromatin fragments from cross-
linked asynchronously growing cells with and without TSA treatment (Input) and on chromatin fragments 
isolated after the immunoprecipitation with HOXC13 antibody with and without TSA treatment (IP 
HOXC13), in serial twofold dilution. The relative abundance of sequences corresponding to the TOP1 
origin, to the MCM4 origin and to the B13 non-origin control was evaluated by probing the extracted 
DNA with sets of three serial two-fold dilutions of the samples, amplified through 35 PCR cycles using 
specific primers for the three sequences153, as previously described.  
 
 
2.8. Dispensability of HOXC13 on the lamin B2 origin 
 
The general character of the interaction of HOXC13 with pre-RC proteins and 
human DNA replication origins, raises the question about the essential role played by 
HOXC13 for origin function. To answer to this question, we studied the effect of 
HOXC13 depletion in the T98G cells and in another cell line, the U2OS, derived from 
osteosarcoma, by either transient or stable shRNA transfection, using a lentiviral vector 
(Open Biosystems) and Polyfect tranfection reagent (Qiagen) following the 
manufacturer's instructions. 
Cells were transiently transfected  with lentiviral vector expressing shRNA 
against HOXC13 and harvest for immunoblotting and FACS analysis at 24h, 48h and 
72h after the transfection. Control transfections with an empty lentiviral vector were 
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used as control. The efficency of the transfections or transductions were monitored by 
GFP expression from the lentiviral vector itself, detected by FACS analyses. We 
obtained at least 70% of the cells transfected in each experiment. Immunoblot analysis 
of RNAi experiments show marked depletion of HOXC13 after 48h from transfection 
with shRNA against HOXC13 in both T98G and U2OS cells. 
As shown by FACS profiles, HOXC13 depletion did not significant modify the 
cell cycle aspects compared with the profiles from the control cells (figure 8.1). The 
same results were obtained using stable transfected cell lines using lentiviral vector 
expressing shRNA against HOXC13 and the empty lentiviral vector as control. Clones 
were obtained by drug selection for 12 days driving by the puromycin resistence gene 
included in the vector itself (figure 8.2). These results suggest a non essential role for 
HOXC13 in the cell cycle progression that is not surprising in light of the observation 
that in mice the mutation of HOXC13 alleles is compatible with life and only causes a 
defect in hair morphogenesis105; actually, HOX-gene knock-out often gives viable 
progenies154. This is suggestive of a redundant availability of other HOX proteins that 












































Figure 8.1. Transiently down regulation of HOXC13 in U2OS cells. Immunoblot analyses 
shows a nearly complete depletion of HOXC13 after 48h from transfection with lentiviral vector 
expressing anti-HOXC13 shRNA. Actin was used as a blot control (upper panel, lower blot). Flow 
cytometry profiles of U2OS cells before and after transient transfection with lentiviral vector expressing 
anti-HOXC13 shRNA or with empty lentiviral vector. The cells were harvested and stained with 

























Figure 8.2. Stably downregulation of HOXC13 in U2OS cells. Immunoblot analyses shows a 
stably depletion of HOXC13. Actin was used as a loading protein control (upper panel). Flow cytometry 
profiles of stably transfected U2OS cells with anti-HOXC13 shRNA or empty vector (lower panel). 
 
 
2.8.1. HOXC13 silencing do not alter the cell cycle progression 
 
We next analysed more in detail the effects of the silencing of HOXC13 in cell 
cycle progression by the analyses of the DNA synthesis. For this assay we used the 
U2OS cells stable transfected with lentiviral vector expressing shRNA against HOXC13 
and with empty vector, used as negative control, and we measured the DNA synthesis 
by bromodehoxyuridine incorporation. We analysed asynchronous growing cells and 
cells synchronized in different phases of the cell cycle by nocodazole, aphidicolin or 
mimosine.  
In the case of asynchronous growing cells we pulsed U2OS stable clones with 
Brdu for 30 minutes or 1 hour. We didn't detect any differences in the Brdu 
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incorporation, and hence in the number of cells in active DNA synthesis, between stable 
clone expressing shRNA against HOXC13 and the stable clone with the empty vector.  
So we went to analysed U2OS stable clones after synchronization to check the 
effects of HOXC13 depletion during the phases of the cell cycle in which HOXC13 
result to be bound to the origins and in which the synthesis of DNA starts. In 
synchronized cells the Brdu was pulsed for 30 minutes before the collection. We were 
mostly  interested in the analysis of the G1 and the G1/S transition phases. Hence, Brdu 
incorporation was measured 0, 2, 4 hours after the release from nocodazole, from what 
we obtained the G1 phase, and 6 and 8 hours after the release from what we obtained 
the G1/S transition and the entry in S phase. We also analysed the DNA synthesis in 
cells incubated with  mimosine or aphidicolin, the blocks the cells in G1-G1/S and 
G1/S-S respectively and 4 hours after the release from the same drugs to obtain cells in 
S phase.  
In all the cases, we did not observed a significant difference in the proportion of 
Brdu incorporation in all the analysed phase between the stable transfected with 
lentiviral vector expressing shRNA against HOXC13 and with empty vector. Especially, 
we did not observed any influence of the HOXC13 depletion in the entry in S phase, 
either after release from nocodazole (figure 8.19 ) neither in cells synchronized by 
mimosine or aphidicolin (figure 8.2 and 8.3), suggesting, as said in the previous 
paragraph, a non essential role of this protein in the DNA synthesis initiation and cell 
cycle progression. Likewise, the depletion of the others HOX proteins known to interact 
with replication origins is compatible with the continuation of the cell cycle. This is 
probably due to the high redundancy of the homeotic proteins and the strong 











































Figure 8.1. HOXC13 depletion does not affect cell cycle progression in cells synchronized by 
nocodazole. Flow cytometry profiles of synchronized U2OS stable clone with empty vector (V) and 
expressing shRNA against HOXC13 (13). The cells were collected directly after the release from 
nocodazole (0h) and 2h, 4h, 6h and 8h after the release. The cells were pulsed with Brdu and stained with 
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an anti-Brdu antibody and with Propidium Iodide and analysed by flow citometry. The percentage of cells 
in the different phases of the cell cycle are indicated: R2 indicates the total amount of the analysed cells; 


























Figure 8.2.  HOXC13 depletion does not affect cell cycle progression in cells synchronized by 
mimosine. Flow cytometry profiles of synchronized U2OS stable clone with Empty vector and 
expressing shRNA against HOXC13. The cells were collected directly after the release from mimosine 
and 4h after the release. The cells were pulsed with Brdu and stained with an anti-Brdu antibody and 
analysed by flow citometry after Propidium Iodide staining. The gated cell population in the different 

























Figure 8.3.  HOXC13 depletion does not affect cell cycle progression in cells synchronized by 
aphidicolin. Flow cytometry profiles of synchronized U2OS stable clone with Empty vector and 
expressing shRNA against HOXC13. The cells were collected directly after the release from aphidicolin 
and 4h after the release. The cells were pulsed with Brdu and stained with an anti-Brdu antibody and 
analysed by flow citometry after Propidium Iodide staining. The gated cell population in the different 
























































DNA replication is a complex, highly regulated process that leads to the 
duplication of the genetic material during cell division. Faithful transmission of genetic 
information to daughter cells requires a coordinate action of several processes and the 
recruiting of replication machinery on thousand sites that function as starting sites, 
called replication origins.  
The knowledge of the mechanisms controlling the initiation of DNA replication is 
the key point to understand the mechanisms of regulation of DNA synthesis and cell 
proliferation. For these reason many efforts are being done to detect the factors involved 
in the initiation of DNA replication, how they are connected each other and how these 
connections are coordinate in space and time. 
In bacteria cells and in budding yeast Saccaromyces cerevisiae it was found that 
the sites used as DNA replication origins were characterized by a conserved sequences 
recognized and bound by the proteins involved in DNA replication. In all the others 
eukaryotes however, the conservation of a consensus sequence used as DNA replication 
origin has never been found and the characterization of the starting sites, lacking a 
common consensus sequence, result to be more difficult. Also in human cells, currently, 
there are very few origins well characterized showing no sequence homologies between 
them.  
In all eukaryotes, the origins are activated by the loading of the pre Replication 
Complex that lead to the formation of two replication forks moving in opposite 
direction to allow the synthesis of new DNA strands. The hexameric ORC complex is 
the factor that for first recognizes a sequence of DNA as replication origin and its 
binding allows the binding of all the other proteins of the pre replicative complex that 
lead to the origin licensing and then to origin firing. In the yeast S. cerevisiae the ORC 
complex recognizes and binds a specific AT rich regions, the ARS sequences, that 
function as starting site. AT richness is a feature generally observed for all eukaryotic 
origins and is assumed to be useful for facilitating the opening of DNA strands at the 
origins. The human ORC complex however, contrary from what observed in S. 
cerevisiae, has no sequence specificity11. Thus, its selective binding to DNA replication 
origin is probably modulated in a different way. The choice of regions to be used as 
origin in fact seems to be influenced by a combinations of elements depending not only 
on the presence of asymmetric AT-rich regions, but also on the presence of GpC island, 
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specific chromatin structure and its post-translational modification, the presence of 
binding sequences for specific transcription factors, the presence of cruciforms 
structures and specific DNA topology. The binding of ORC could be defined by these 
elements and also by the interaction with other unknown factors. 
Moreover, among the mechanisms controlling the origins activity, a great 
relevance for cell cycle progression is assumed by those that limit the initiation of DNA 
replication to once per origin in each cell cycle. Not all origins are used during each cell 
cycle and those fired cannot be used a second time until the following cell division. 
Several mechanisms have been identified that limit initiation of eukaryotic DNA 
replication to once per origin for each cell division. Probably, these mechanisms 
evolved to avoid the genomic instability that would result if some sequences were 
duplicated more than others and replication forks remained during mitosis.  
Many studies are ongoing with the scope of identification of other proteins 
involved in the specification and activation of DNA replication origins. To this purpose, 
well characterized and genetically defined origins were used to analysed the factors that 
influence the choice of a site as DNA replication origin. It was found that some of 
characterized origins are functional when moved to ectopic chromosomal locations, as 
for the lamin B2150. Hence, the origins seem to be site-specific and genetically 
determined in all organisms, but the nature and the role of the sequence determinants of 
origins might be given to others levels of organization of the origins57 and even if the 
origins might be defined by specific combinations of sequence elements, it might not be 
a single consensus combination that defines an origin. Difficulties in studying whether 
specific sequence elements can initiate DNA replication might arise from a requirement 
for synergistic effects between separate, weak, but nevertheless specific, sequence 
elements that collaborate with other factors. 
In particular, replication origins are shown to be frequently associated with coding 
genes and with CpG islands, regions that are largely bound by transcription factors. 
Thus, the transcription factors result to be between the factors involved in the regulation 
of origin selection and for them the suggested role in this process is the recruitment 
directly or indirectly of subunits of the pre replicative complex. 
From the study of the mechanism regulating the specification and activation of 
DNA replication derives the indication of an involvement of the HOX proteins as 
factors able to play a role in replication origin activity. The HOX proteins are 
transcriptional factors involved in the development of the metazoan assigning positional 
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identities along the embryonic body. They are characterized by the presence of a very 
highly conserved homeodomain, that enables the HOX proteins to bind the DNA. 
Beside the increasing evidence for a close association between transcription 
factors and DNA replication, a clear connection with HOX proteins and the machinery 
controlling the cell cycle progression have been identify also in the interaction with the 
regulator Geminin. Through the interaction with Cdt1, Geminin prevent the replication 
by the transiently association with members of the HOX-repressing polycomb complex, 
with the chromatin of HOX regulatory DNA elements and with the HOX proteins 
themselves117. 
One of the first indication of a direct connection between DNA replication and 
HOX proteins comes from our group, that in a previous work found a specific binding 
of three different HOX proteins to a portion of the lamin B2 origin. The portion of the 
lamin B2, previously showed to be bound by the pre Replication Complex in S phase, 
was used as bait in a one hybrid screening assay. This lead to the identification of three 
homeotic proteins: HOXC10, HOXC13 and HOXA13. For both HOXC10 and 
HOXC13 was further showed an high  affinity in vitro for the origin, demonstrated by 
EMSA assay and CAT assay. About HOXC10, it was shown a timely degradation by 
anaphase promoting complex APC, that lead to the disappearance of the protein in the 
cells during the mitosis, and the affection of this degradation on the progression from 
metaphase to anaphase.  
In the present study we wondered if the same affinity observed in vitro between 
HOXC13 and the lamin B2 origin is present also in vivo and how this protein could be 
involved in the DNA replication. 
To analyse the behaviour of HOXC13 in human cells and its in vivo interaction 
with lamin B2 origin, our group produced polyclonal antibody against this protein. 
Rabbits were injected with a purified GST protein lacking the very highly conserved 
homeodomain, in order to generate a more specific antibody. First of all, it appeared 
essential to prove the goodness of this antibody in recognition clearly and with high 
specificity the right protein, considering the conservation and the redundancy of the 
these factors, especially for those homeoproteins derived from the same paralogue 
group. The many proves made demonstrate that the antibody is specific in antigen 
recognition also in a total cell extract and that it can be used for different application. 
Hence, we obtained first general indications about the expression in different cell 
types, that is variable respect to the analysed cells, showing some cell lines with 
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irrelevant level or with big expression of HOXC13 protein. The cells with an 
appreciable level of HOXC13 also show a constant level in its expression. In the 
analysed cases, HeLa and T98G cells, in fact, during the entire cell cycle the amount of 
HOXC13 does not varies, as showed for HOXD13149, another HOX protein interacting 
whit the human origins, which level is constant throughout the cell cycle, but differently 
from what already observed for the HOXC10155. 
In order to explore the direct interaction of HOXC13 with the human DNA 
replication origin lamin B2 we performed a chromatin immunoprecipitation assays and 
we found that HOXC13 binds in vivo to the lamin B2 origin. This interaction is also 
extensible to others origins, as we observed for the TOP1 and MCM4 origins, leading to 
infer that HOXC13 is stably bound to at least a good fraction of the origins, specifically 
the early replicating ones, to which all the three tested origins belong and that represent 
anyhow the majority. This hypothesis was further confirmed by our observation that 
HOXC13 does not bind the late firing replication origin β-globin. 
HOXC13 is bound to origin chromatin, at least for the lamin B2 origin, at a 
precise site within the pre-RC and at a specific phase of the cell cycle. The interaction 
with the origin occur within the area covered by the pre-replicative complex in G1 
phase and its binding is very close to the start site of leading strand synthesis and to the 
binding sites of ORC1, ORC2, Cdc6, topoisomerase I and topoisomerase II47, 80. Using 
synchronized cell cultures, we found that the protein is absent from the origins in 
mitosis and appears on them at the beginning of G1, reach a peak at G1/S, and in S 
phase, when the DNA synthesis starts, the interaction of HOXC13 with the origins 
fades, in parallel with the transition from the large pre-RC to a smaller and differently 
organized post-RC, that marks the end of the origin activity and prevent the re-licensing 
of the origins30. 
The mechanism by which HOXC13 interacts with the origins involved also its 
interaction with at least two important factors of the pre Replication Complex. We 
found indeed, by GST pull down and co-immunoprecipitation assays, that HOXC13 
interacts with Cdc6 and ORC1, two crucial elements for origin recognition and 
licensing, that allow the pre-RC assembly. The observed interaction with Cdc6 is 
mediated by the central portion of Cdc6 and HOXC13 homeodomain. The same was 
found about HOXD13, where the interaction of the protein with Cdc6 is mediated again 
by its homeodomain149. The binding of HOXC13 with these two proteins is significant 
because these are the first factors involved in the origins licensing.  
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Since the connection between the morphogenetic function of homeotic proteins 
and the regulation of cell cycle progression, as well as the cancer role of HOX proteins 
in modulating cell proliferation was amply demonstrated118, 122, we asked which specific 
role can we ascribe to the binding of HOXC13 to a large fraction of replication origins, 
in the context of the pre-RC assembly. It is tempting to hypothesize that homeotic 
complexes could contribute to the specification of origins in the genome, considering 
the lack of consensus sequence in metazoan origins, apart from a relative frequency of 
asymmetric AT-rich sequences156. Actually, also the HOX proteins recognize and bind 
the DNA without a stringent sequence specificity in vitro and preferentially bind AT 
rich regions. The HOX proteins achieve a high specificity in vivo by the cooperation 
with other DNA-binding cofactors. This observation suggests the hypothesis that the 
observed interaction of HOXC13 with the origins, in all probability, occurs in the 
context of a multi-protein homeotic effectors and other factors, rather than sequences, 
provide the appropriate conditions for the assembly of the pre-RC in defined starting 
sites. The finding that the interaction of the origins with HOXC13 occurs in the absence 
of sequence conservation, as demonstrate by the fact that the three origins lamin B2, 
TOP1 and MCM4 do not contain any motif similar between them, support this idea. 
This conclusion is further suggested also by the recent observations that other homeotic 
proteins as HOXC10, studied by our group, HOXA13, also previously found in the one 
hybrid assay, HOXD11 and HOXD13 bind the lamin B2 origin as well as other origins 
in vivo6,7; in this perspective, we should expect that, besides HOXC13 and the others 
already showed, other homeotic proteins may display an interaction with DNA 
replication origins. Depletion of one of these proteins however is compatible with the 
continuation of the cell cycle, probably thanks to the redundancy of homeotic protein 
structures that permit to a missing protein to be substitute in the complex by an 
analogous one, indicating a relatively generic function for the HOX protein rather than a 
precise requirement for a specific homeotic protein. In this view, it was not surprising 
our finding that depletion of HOXC13 does not alter cell cycle progression or S phase 
entry. The recent observation by Salsi et al. that depletion of HOXD13 instead delays 
the initiation of DNA synthesis represent the only case in which the depletion of an 
homeotic protein causes a delay in DNA synthesis initiation but this strong result could 
be due to a synergistic silencing effect when using siRNA targeted to highly conserved 
protein sequences like that of the homeodomain as in Salsi et al.. This further reinforce 
our model suggesting that the complete or partial depletion of several HOX proteins, at 
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least those paralogs to the HOXD13 one (the Abd-B paralogs, to which class all HOX 
proteins so far found to bind the replication origins belong to), and not the depletion of 
just one homeotic protein, lead to a delay of DNA synthesis. 
Among the elements indicated as factors that influence the choice of a region as 
DNA replication origin, much relevance is given on the DNA topology and chromatin 
structure. It is widely accepted that chromatin structure around a promoter modulates 
the transcriptional activity of genes. Activators and suppressors of transcription often 
remodel chromatin by modifying or repositioning the histones. Histone acetylation is 
linked to opening chromatin for gene activation. Notably, histones around ORC binding 
sites are hyperacetylated during gene amplification in Drosophila follicle cells14 and 
also nucleosome repositioning is involved in general chromatin remodelling events. 
These aspects are closely interrelated, affect each other and depend also on relatively 
long-range effects of DNA sequence, such as the tendency to form unusual DNA 
structures and to bend the duplex.  
The lamin B2 origin sequence is characterized by an intrinsic tendency to form 
such unusual structures157 and contains a bent DNA sequence between nt 3923 and 
3928. Furthermore, topological status is clearly critical for origin recognition by ORC in 
yeast and Drosophila origins8, 158, while the topoisomerases I and II, that are the 
modulators of DNA topology inside the cell, bind precise sites in the lamin B2 pre-RC 
area in precise moments of the cell cycle, topoisomerase I being essential for DNA 
synthesis initiation80.  
To analyse the influence of the topological state of the chromatin on the observed 
involvement of HOXC13, we study the effects of the Tricostatin A (TSA), the most 
potent inhibitor of histone deacetylase (HDAC). The acetylation of chromatin is an 
important post-translational modification that regulates the chromatin structure and it is 
the result of the activity of the histone acetyltransferases and deacetylases on the 
nucleosome. 
We found that the disruption of chromatin structure caused by TSA treatment not 
only sharply reduces origin function, as already shown71 but also disturbs the binding of 
replication complex members like the new HOXC13 and the well known Cdc6. After 
TSA treatment in fact, HOXC13 lose its affinity for all the three analysed origins. We 
observe the same for Cdc6, that we also found interacting with HOXC13, while the 
treatment does not affect the binding of USF1 to the TIMM promoter, that is located 
only 50 bp away from the right border of the replication complex, and that, contrary to 
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what happens with replication complex members, remains constant bound throughout 
the cell cycle. 
This finding lead us to conclude that an appropriate chromatin organization of the 
origin area appears to be required for the formation of an active replication complex 
since chromatin disruption does not affect other different protein-DNA interactions even 
if these interactions occur in close proximity, but are not related with the pre-replication 
complex formation.  
Previously, the positions of the human ORC1, ORC2 and Cdc6 at the lamin B2 
origin were mapped with nucleotide resolution for the mitosis, middle of G1 and S 
phases of the cell cycle. Subsequently, the data obtained for topoisomerase I and 
topoisomerase II lead to new picture of the dynamic interaction of the origin binding 
proteins with the DNA80.  
Now our data indicate that HOXC13 represent a new member of the pre 
Replication Complex. Its function in the origin activity could be related to its specificity 
for DNA binding that might allows, in association with other cofactors, the specification 
of the sequence that have to be bound to start the DNA replication. Moreover, we 
further demonstrate that structural features of chromatin at the origins appear to play an 
important role in origin function also through the modification of proteins binding, 
rather independently from the detailed sequence features. 
The important role of HOXC13 in DNA replication is also underlined by their 
involvement in oncogenesis. Principally, it was clearly demonstrate to determine an 
acute myeloid leukaemia when fused with NUP98 protein128, such as observed for the 
other two components of the pre replicative complex, topoisomerase I and II. 
Nevertheless, the emerging idea is that all the HOX proteins identified up to now, 
HOXC13 included, and the others that probably would be discovered on the origins, are 
not essential for the cell cycle progression, probably because the large redundancy of 
the HOX proteins in the metazoan cells. It appears indeed that the combination of the 
structural features in an appropriate cellular context, with certain essential proteins 







3.1.Conclusion and future perspective 
 
We show in this study that HOXC13 is a new member of the human pre 
Replication Complex. This protein in fact, directly interacts with two crucial factors of 
the pre replicative complex, ORC1 and Cdc6. About the interaction with Cdc6 we also 
found that the domains involved are the central portion of Cdc6 and the homeodomain 
of HOXC13. 
Furthermore HOXC13 is bound to the early firing replication origins in a time 
dependent manner. Its binding reach a maximum in the G1/S border phase while 
disappear in S phase, when the cells start the DNA synthesis, and then remains unbound 
to the origin until the following G1 phase.  
We also found that the binding of HOXC13 to the origins depend on DNA 
topology. After a TSA treatment in fact, we observed the loss of the interaction with all 
the tested origins. This behaviour is in common with the behaviour of one of the 
HOXC13 interacting protein, Cdc6, further demonstrating the involvement of this 
protein in the pre-RC. Conversely in fact, the binding of proteins bound near the pre 
replicative complex but not included in the complex itself, is not affected by the TSA 
treatment. We conclude that DNA topology strongly influence the binding between 
factors of the pre Replication Complex and DNA replication origins. This influence 
could be the key element in origin specification. 
Since recently also others HOX proteins have been identify as proteins involved 
in regulation processes of DNA replication, we suggest that the interaction of HOXC13 
with the origins might occur in a multi-homeotic proteins complex. 
Hence, the sequel of this project could be the study of the interaction of HOXC13 
with others factors of DNA replication, either the already known members of pre 
replicative complex and others HOX proteins. 
It could be interest also investigate the presence of specific HOX cofactors in the 
pre-RC. The HOX proteins in fact, achieved a stringent sequence specificity 
cooperating with their cofactors. The presence of these cofactors directly in the pre 
replicative complex or associated with its members in specific moments preceding the 
loading of pre-RC could be explain also the presence of HOX proteins as driving factors 





































4.Materials and Methods 
 
 
4.1.Cell culture, synchronization and TSA treatment  
 
HeLa, T98G and U2OS cells were grown as monolayers in complete Dulbecco’s 
modified Eagle’s medium (DMEM), supplemented with 2 mM glutamine, 1 mM 
sodium pyruvate, 10 U/L penicillin, 10 μg/L streptomycin and 10% fetal bovine serum 
FBS (Gibco) and kept in a 5% CO2 atmosphere at 37°C. 
T98G cells were synchronized in G0 phase by incubating cells for 72h in DMEM 
serum free and collected at different times after the release in completed medium with 
20% FBS to obtain synchronized cell populations at different stages of cell cycle159.  
In the analyses of the HOXC13 protein levels during cell cycle, T98G cells were 
synchronized and collected immediately after the 72h of incubation in serum free 
medium to obtain G0 phase population; 6h, 10h, 16h for the early, mid and late G1 
respectively; 20h for G1/S transition; 24h for S phase; 28h for G2 and 32h for G2/M 
phase. To arrest the cells in G2/M phase, T98G were initially treated 17h with 2.5 mM 
thymidine (Sigma), release 9h in completed medium and treated 17h with 50 ng/ml 
nocodazole (Sigma) and subjected to mitotic-shake off for the collection.  
For ChIP assays, the T98G cells were synchronized in G1 by collecting them 5h 
after serum deprivation; to arrest the cells in late G1, G1/S border and S phases, they 
were treated with 0.5 mM mimosine for 24h and collected directly, and immediately 
after 2h and 6h the mimosine release respectively. For cell synchronization in G2/M 
transition was also used the same thymidine/nocodazole treatment described before. 
HeLa cells were synchronized in M phase by sequential treatment with 2.5 mM 
thymidine for 17h, washed and released in fresh medium for 9h and, finally blocked 
with 50 ng/ml nocodazole for 15h. For subsequent synchronization through the G1 to 
the S phase, mitotic HeLa cells were shaken-off, washed and released in fresh medium 
at different times: 5h for G1 phase, 10h for G1/S border and 15h for S phase. 
For BrdU incorporation experiments, U2OS cells were synchronized by: 100 
ng/ml nocodazole treatment, release in nocodazole-free medium and collected 0, 2, 4, 6, 
8h after the release to obtain G2/M, early G1, mid G1, late G1 and G1/S transition. 
Cells in late G1 and early S, were obtained by 0.5 mM mimosine treatment, collected 
after treatment and release in mimosine free-medium and collected at 4h after treatment 
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respectively. Cells in early S and late S were obtained by 5 µg/ml aphidicolin treatment, 
collected after treatment and release in aphidicolin free-medium and collected after 4h 
of release, respectively. Cells were collected, stained with propidium iodide and 
analyzed by flow cytometry analysis on a FACSCalibur (Becton Dickinson) instrument, 
to determine the cell cycle profile based on DNA content, and follow S phase 
progression by incorporation of BrdU (SIGMA). 
The HeLa and T98G stable clones expressing recombinant HOXC13 tagged with 
HA and Flag were produced by transfection of pFHIresNeo vector in which HOXC13 
was previously cloned. The transfections were performed using Polyfect according to 
the manufacturer's instructions. The stably transfected clones were selected by adding 
G418 drug in the medium for at least 2 weeks. 
For TSA treatment, asynchronously growing T98G cells were incubated for 4h 
with 100 ng/ml TSA (Sigma) in complete medium. Before the ChIP assay, the cells 
were washed twice with PBS supplemented with the same drug concentration and lysed 





The following antibodies were used: rabbit polyclonal anti-HOXC13 produced 
and purified by immunization of rabbits with GST-tagged HOXC13 1-259, that lacks 
the conserved homeodomain; rat monoclonal anti-HA (Sigma), mouse monoclonal anti-
tubulin (Sigma), mouse monoclonal anti-Cdc6 (clone D-1, Santa Cruz Biotechnology), 
mouse monoclonal anti-Cyclin A (Sigma), rabbit polyclonal anti-Cdc6 ( clone H-304, 
Santa Cruz Biotechnology), rabbit polyclonal anti-USF1 (clone C-20, Santa Cruz 
Biotechnology), mouse monoclonal anti-β-Actin (clone C-4, Santa Cruz 
Biotechnology), mouse monoclonal anti-BrdU antibody (Abcam), anti-mouse secondary 
antibody Alexa Fluor 488 (Cat.A-11017). 
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4.3.Preparation of Nuclear Extracts 
 
HeLa cells were washed in PBS, harvested and resuspended in 5 vol. of RSB 
buffer (10 mM Tris pH 7.4, 10 mM NaCl, 3 mM MgCl2). After 10 min of incubation on 
ice, samples were centrifuged at 1200 rpm for 10 min. The pellet was resuspended in 
2.5 vol of RSB buffer with 0.2% NP40 and incubated on ice for 15 min. Cellular debris 
were removed by 3500 rpm centrifugation. The purity of the nuclei was checked by 
microscopy. Then the pellet was resuspended in 1 ml of RIPA (1% deoxycholic acid, 
1% Triton X-100, 0.15 M NaCl, 0.05 M Tris PH 7.5) and the nuclei were incubated 10 
minutes in ice. After 1 ml of RIPA 0.1% SDS was added to the lysate and incubated for 
15 minutes in ice. The described buffers were supplemented with protease inhibitors 1 
mM PMSF and protease inhibitors cocktail tablet (Roche).  




4.4.Western blot analyses 
 
The extracts and the immunoprecipitates were run on a 10% or 12% SDS-PAGE, 
the proteins transferred to a nitrocellulose membrane (Amersham) using a wet transfer 
system (Biorad). The membrane was block in 5% milk in TBST for 1h at room 
temperature. The primary and secondary antibodies were diluted in 5% milk in TBST. 
All the primary antibodies were incubated overnight a 4°C, with exception for antibody 
against HOXC13, incubated for 90 minutes at room temperature. The secondary 
antibodies were all incubated for 1h at room temperature. 
For immunoprecipitations the membranes were blocked 1h with ReliaBLOT 
reagents (Bethyl Laboratories) to reduce the background from heavy chains. The 
membranes were then incubated for 1hour and 30 minutes with the primary antibody 
against HOXC13, diluted in the same kind of milk and TBST and followed by 3 washes 
in TBST (45 minutes in total). The secondary antibody, diluted in milk and TBST, was 
incubated for 1h and then 3 washes with TBST were repeated. All the steps were 
performed at room temperature. The SuperSignal® West Femto Maximum Sensitivity 





Linear gradient gels were made mixing two solutions with different acrylamide 
concentration. We choose a range of concentration of 9%-16%, based on the size of 
HOXC13. The mixture with lower acrylamide concentration was composed by 17.6 ml 
of H2O, 10.1 ml Tris 1.5 M pH 8.8, 0.2 ml sodium thiosulfate 5%, 12 ml 30% 
acrylamide, 0.002 TEMED and 0.2 10% ammonium persulfate. The mixture with 16% 
of acrylamide is composed by 3.3 ml H2O, 9.3 ml Tris 1.5 M pH 8.8, 4.3 ml of 85% 
glycerol, 0.18 ml sodium thiosulfate 5%, 19.7 ml 30% acrylamide, 0.002 TEMED and 
0.2, 10% ammonium persulfate. Both solution were degassed under vacuum for 1 
minute and poured in gradient maker. The mixed solution filled the gel apparatus using 
a pump speed. When the separating gel was prepared, a normal stacking gel was added. 
 
 
4.6.Partial proteolytic peptide maps 
 
To prepare samples for enzyme treatment, we run on a preliminary gel multiple 
lanes of the recombinat protein and 50 μg of total extract from T98G cells boiled in 
loading buffer. Recombinant protein bands from different lanes were the substrate for 
enzymatic digestions with different enzyme concentrations. 
The preliminary gel is a normal SDS-polyacrylamide gel. This gel was stained 
with Coomassie and dry on a paper. The bands of interest were excised and the backing 
paper removed from each slice with a scalpel.  
We prepared another polyacrylamide gel including 1 mM EDTA, 15% of 
acrylamide for separating gel and with a stacking gel of about twice the normal depth, 3 
cm from the bottom of the well to the top of the separating gel. The wells of the 
stacking gel were filled with 0.1% SDS, 1 mM EDTA, 2.5 mM dithiothreitol and 0.125 
M Tris pH 6.8. In this wells were pushed the dried gel slices previously prepared, and 
there were incubated for 10 minutes to allow the equilibration between slices and buffer. 
Then the gel slices were overlay first with a mix of 20 μl of 20% glycerol, 0.1% 
SDS, 1 mM EDTA, 2.5 mM dithiothreitol and 0.125 M Tris pH 6.8, and then with 
another mix of 10 μl of 10% glycerol, 0.1% SDS, 1mM EDTA, 2.5 mM dithiothreitol, 
0.001% bromphenol blue, and 0.125 Tris pH 6.8 containing a dilution of Trypsin.  
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The right concentration of Trypsin was previously checked to set the condition for 
the final experiment using different times, from 30 to 80 minutes of incubation and 
different dilutions, between 50 ng and 20 μg of this enzyme on recombinant HOXC13 
protein. We obtained the best result using 20 μg of trypsin for 80 minutes. Thus we used 
20 μg of trypsin in the mix.. 
The gel was run in normal running buffer at 125 V until the bromphenol blue 
formed a sharp line and had migrated about two-thirds of the distance into the stacking 
gel. At this point the run was turned off for 80 minutes to allow the protein digestion at 
room temperature. 
Then the run was continued until the bromphenol blue reached the bottom of the 






Formaldehyde was diluted to 1% in PBS and added to the monolayer of cells at 
about 70% of confluence for 10 minutes. The reaction was stopped by glycine at a final 
concentration of 0.125 M. The cells were incubated on ice in hypotonic RSB buffer (10 
mM Tris-HCl pH 7.5, 10 mM NaCl, 3 mM MgCl2) for 10 minutes, then an equal 
volume of RSB with 0.2% NP40 was added for 10 minutes again. After washes with 
PBS, high salt NBS buffer (1 M NaCl, 10 mM Tris-HCl, 0.1 NP40,1 mM EDTA) and 
with low salt NBS buffer (0.1 M NaCl), the cells were collected by scraper in MNase 
buffer (20 mM Tris-HCl pH 7.5, 15 mM NaCl, 1 mM CaCl2) and incubated on ice for 
about 1 hour. The described buffers were supplemented with protease inhibitors 1mM 
PMSF and protease inhibitors cocktail tablet (Roche).  
At this point the cells were subject to micrococcal nuclease digestion with 125 U 
of MNase (Roche) for about 1-2x107 cells at 37°C for 15 minutes to limit the maximum 
lengh of each fragment to 160 bp to less than 1000 bp. Digestion was stopped adding 
SDS lysis buffer (SDS 10%, EDTA 0.5 M, Tris-HCl 1 M, pH 8). The cell lysetes were 
also sonicated 5 times for 30 seconds to shear further the DNA and centrifuged to pellet 
debris.  
Protein concentration was estimated by Bradford assay (Pierce) and ~1.5 mg of 
protein was used for each immunoprecipitation. We performed a pre-clearing step 
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incubating the samples with 30 μl Protein A from Chromatin Immunoprecipitatio 
(ChIP) Assay Kit (Millipore) for 1h at 4°C and then the lysates were used for the 
immunoprecipitation with polyclonal rabbit anti-HOXC13 generated against GST–
HOXC13: 1-260 that lacks the conserved homeodomain and affinity purified (Viva 
Science kit, Sartorius group), or with Cdc6 rabbit polyclonal anti-Cdc6 (clone H-304, 
Santa Cruz Biotechnology), with polyclonal antibody against USF1 as a positive control 
and with specific rabbit IgG's as negative control. After an overnight incubation with 
the antibodies, the immunocomplexes were recovered by incubation of 70 μl of Protein 
A for 5h at 4°C. 
The immunocomplexes were washed with low salt buffer (0.1% SDS, 1% Triton 
X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8, 150 mM NaCl ), High salt buffer (500 
mM NaCl ), LiCl  buffer (0.25 M LiCl, 1% IGEPAL, 1% deoxycholic acid, 1 mM 
EDTA, 10 mM Tris-HCl, pH 8 ) and TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8). 
The washed precipitates were divided for Western blotting and DNA extraction. 
Before the DNA extraction, the immunopurified complexes were incubated at 
37°C for 1h with Ribonuclease A enzyme to degrade RNA in the sample, and at 65°C 
over night with Proteinase K enzyme, to revert the crosslink and to digest and remove 
the proteins from the preparations. DNA was extracted with phenol:chloroform:isoamyl 
alcohol (Invitrogen), ethanol precipitated and resuspended in 30 μl of TE buffer. The 
quantification of the abundance of different sequences in immunoprecipitated DNA was 





The human full length HOXC13 cDNA was constructed by PCR amplification of 
HOXC13 cDNA and cloned into pGEX 20T vector for GST fusion protein production 
and in pcDNA3 vector (Invitrogen) for in vitro transcription and translation 
experiments. The HOXC13 deletion mutants for the GST pulldown assays (1-257, 260-
330) were obtained as BamHI-EcoRI fragments. The HOXC13 full length, 
aminoterminal and carboxyterminal, the Cdc6 full length, aminoterminal and 
carboxyterminal (1-363, 364-561), ORC1, MCM2 and MCM3 cDNA were cloned into 
the pcDNA3 vector (Invitrogen) for in vitro transcription and translation. 
 107
For the stably expressing HOXC13 HeLa and T98G cell lines, full length 
HOXC13 cDNA was cloned into pFHIresNeo vector and transfected in the cells. This 
vector contains the NeoR resistance gene for mammalian selection in G418 drug and 
Flag and HA aminoterminal tags for tagging the target protein. 
All constructs were verified by nucleotide sequencing before use. 
 
 
4.9.GST pull-down assay 
 
[35S]-labelled proteins used for in vitro binding assays were produced by using the 
TNT Reticulocyte Lysate System (Promega) according to the manufacturer’s 
instructions, by using the corresponding pcDNA3 vectors as templates. The 
recombinant GST fusion proteins were produced and purified from BL21 bacteria 
transformed with the respective plasmids. Bacterial cultures were grown in culture broth 
+ ampicillin and protein production was induced with IPTG 1 mM for 4 hours at 30°C 
until the OD600 was between 0,6 and 0,8. Bacteria were then resupended in Cold lysis 
buffer (50 mM TrisHCl pH 8, 5 mM EDTA pH 8, 250 mM NaCl, 5% glycerol, 
proteases inhibitor) and sonicated. Bacterial lysates were mixed with a 50% slurry of 
glutathione cross-linked agarose beads and the GST-fusion proteins were allowed to 
bind the beads at 4°C on a rotating wheel for 1 hour. The suspension was then loaded on 
an empty plastic column, letting the unbound proteins pass through, and the beads were 
washed with lysis buffer. The purity and integrity of the proteins were routinely checked 
by SDS-PAGE and Coomassie blue staining. To remove contaminant bacterial nucleic 
acids, recombinant proteins were pretreated with nucleases (0.25 unit/μl DNase I and 
0.2 μg/μl RNase) for 1 hr at 25°C in 50 mM Tris HCl, pH 8, 5 mM MgCl2, 2.5 mM 
CaCl2, 100 mM NaCl, 5% glycerol, 1 mM DTT. Then the GST fusion proteins 
immobilized on agarose beads were washed and resuspended in NETN buffer (20 mM 
Tris HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, 1 mM DTT/1 mM 
phenylmethylsulfonyl fluoride) supplemented with 0.1 mg/ml ethidium bromide to 
impede the possible formation of nonspecific interactions between residual DNA and 
proteins. 35S-labeled proteins was added and incubated at 4°C on a rotating wheel. 
After 1hr, bound proteins were washed five times with 1 ml of NETN buffer and 
separated by electrophoresis in an SDS-7% polyacrylamide gel. Dried gels were 
quantitated by phosphoimaging (Cyclone). 
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4.10.Competitive PCR analysis 
 
Competitive PCR was performed using primer sets B48 and B13: 
B48 Dx: 5’-GACTGGAAACTTTTTTGTAC-3’ 
B48 Sx: 5’-TAGCTACACTAGCCAGTGACCTTTTTCC-3’  
B13 Dx: 5’-GCCAGCTGGGTGGTGATAGA-3’  
B13 Sx: 5’-CCTCAGAACCCAGCTGTG-3’ 
The quantification of the abundance of the origin (B48) and non-origin (B13) 
DNA fragments was performed as described previously150. The B48 amplification 
reaction contained 10μl 5x Taq polymerase buffer Green (Promega), 3 mM MgCl2, 1μl 
(10pmol) of each primer, 1μl dNTPs (10 mM each), 0,5μl GoTaq polymerase (2 U/μl) 
(Promega), 5μl of purified DNA, 5μl competitor DNA and H2O up to 50μl.  
The B13 amplification reaction contained 10 μl 5x Taq polymerase buffer Green 
(Promega), 1 mM MgCl2, 1μl (10pmol) of each primer, 1μl dNTPs (10 mM each), 0,5μl 
Taq polymerase (2 U/μl) (Promega), 5μl of purified DNA, 5μl competitor DNA and 
H2O up to 50μl. The amplification conditions for both B48 and B13 were:  
In PCR cycle, an initial denaturation of 4 minutes at 94°C for 5 minutes was 
followed by 35 cycles with denaturation for 30 seconds at 94°C, annealing for 30 
seconds at 56°C, polymerization for 30 seconds at 72°C, and a final extension for 5 
minutes at 72°C. 
A constant volume of immunopurified DNA was coamplified with decreasing 
amounts of competitor template. The competitor consists of a 130 bp stuffer DNA 
flanked by the target sequences for B13 and B48 primer sets and was obtained as 
already described146. Amplification products were resolved on 8% acrylamide and 
stained with ethidium bromide. The intensity of the amplification band was quantified 
with the NIH-Image program (version 1.62). 
 
 
4.11.PCR with multiple pairs of primers 
 
PCR primers were designed from the known sequences of the analysed origins 
TOP149, MCM4152, Beta globin and B13 was used as non origin control: 
TOP1 Dx: 5'-CACTGCCTAGCAGAGGGGCT-3' 
TOP1 Sx: 5'-GCAGTTGTGTAACAGCCTAAGTTCG-3' 
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MCM4 Dx: 5'-GTCTGACCTGCGGAGGTAGTTTGG-3' 
MCM4 Sx: 5'-TGGTCTCGAACTCCTGCGATCCCC-3' 
Betag Dx: 5'-GTTGCCCATAACAGCATCAG-3' 
Betag Sx: 5'-CTGCCGTTACTGCCCTGTGGG-3' 
B13 Dx: 5’-GCCAGCTGGGTGGTGATAGA-3’ 
B13 Sx: 5’-CCTCAGAACCCAGCTGTG-3’ 
Three pairs of primers were used together in each PCR reaction. The conditions 
for the equal amplification of the three distinct fragments were set up using purified 
DNA from synchronized quiescent T98G cells. Three serial two-fold dilutions were 
used for the DNA of each sample.  
The amplification reaction contained 10 μl 5x Taq polymerase buffer Green 
(Promega), 3 mM MgCl2, 1μl (10pmol) of each of three pairs of primers, 1.25 μl dNTPs 
(10 mM each), 1 μl Taq polymerase (2 U/μl) (Promega), 10 μl of purified and diluted 
DNA and H2O up to 50μl.  
In PCR cycle, an initial denaturation of 4 minutes at 94°C for 5 minutes was 
followed by 35 cycles with denaturation for 30 seconds at 94°C, annealing for 30 
seconds at 60°C, polymerization for 30 seconds at 72°C, and a final extension for 5 
minutes at 72°C. 
Amplification products were resolved on 8% acrylamide and stained with 
ethidium bromide. The intensity of the amplification bands was quantified with the 
NIH-Image program (version 1.62). 
 
 
4.12.ChIP and dimethylsulfate (DMS) treatment 
 
HeLa cells were crosslinked by adding 1% formaldehyde and incubation for 10 
min. After stopping the crosslinking reaction by adding 0.125 M glycine and incubation 
for 5 min, the cells were pelleted at 2000 r.p.m. The cells were then washed twice in 25 
ml ice-cold phosphate-buffered saline (PBS) including protease inhibitors. Nuclei were 
isolated by resuspending the cell pellet in 1 ml ice-cold swelling buffer (5 mM PIPES 
pH 8.0, 85 mM KCl, 0.5% NP-40 and protease inhibitors), split into two aliquots and 
incubated on ice for 10 min. Chromatin was fragmented by subjecting the nuclei to 
restriction enzyme digestion with 200 U PstI for 4 h at 37°C and 100 U PstI for an 
additional 16 h at 37°C. The nuclei were then incubated with 200 U RNase cocktail 
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(Ambion) and an additional 100 U aliquot of PstI for 2 h at 37°C. Nuclei were pelleted 
at 4°C for 5 min at 5000 r.p.m. and lysed in 1 ml lysis buffer (1% SDS, 10 mM EDTA 
and 50 mM Tris–HCl pH 8.1) on ice for 20 min. The lysate was combined and 
transferred to a 15 ml conical tube and diluted with 9 ml dilution buffer (0.01% SDS, 
1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris–HCl pH 8.1, 167 mM NaCl and 
protease inhibitors). An aliquot of 500 µl protein A–Sepharose beads (Pharmacia) was 
added to the diluted nuclear lysate and incubated for 2 h at 4°C while rotating. The 
beads were pelleted for 10 min at 2000 r.p.m. and the supernatant was divided into three 
aliquots. An aliquot of 25 µl of the appropriate antibody (USF1 or NF-E2; Santa Cruz 
Biotechnology) or no antibody was added to the aliquoted supernatant and incubated at 
4°C overnight while rotating. Protein A–Sepharose beads were washed twice in 
blocking buffer [3% BSA, 0.05% sodium azide, and protease inhibitor in 1× TE (10 
mM Tris–HCl pH 8.1, 1 mM EDTA)]. The chromatin was then immunoprecipitated 
with 600 µl blocked protein A–Sepharose for 2 h at 4°C on a rotator. The 
immunoprecipitates were pelleted at 13 000 r.p.m. for 30 s and 1 ml of the no antibody 
supernatant was saved and labeled as ‘input’. Half of the input chromatin was ethanol 
precipitated and resuspended in two aliquots of 20 µl ddH2O and 800 µl DMS buffer 
(50 mM sodium cacodylate, 1 mM EDTA) and the other half was saved for the 
ChIP/PCR analysis. The supernatants of the samples precipitated with USF1 and NF-E2 
antibodies were discarded and the pellets were washed by rotating at 4°C for 5 min with 
1 ml each of low salt wash (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris–
HCl pH 8.1 and 150 mM NaCl), high salt wash (0.1% SDS, 1% Triton X-100, 2 mM 
EDTA, 20 mM Tris–HCl pH 8.1 and 500 mM NaCl), LiCl wash (0.25 M LiCl, 1% NP-
40, 1% sodium desoxycholate, 1 mM EDTA and 10 mM Tris–HCl pH 8.1) and twice 
with TE. Of the immunoprecipitates, 80% was resuspended in 800 µl DMS buffer and 
20% was left in TE buffer for the ChIP/PCR analysis. 
DMS treatment of the immunoprecipitated chromatin was performed using the 
Maxam and Gilbert guanine-specific sequencing reaction with 0.1% DMS for 15, 45 or 
90 s at room temperature. The reaction was stopped by adding 50 µl DMS stop buffer 
(1.5 M sodium acetate pH 7.0, 1 M 2-mercaptoethanol), followed by two ethanol 
precipitations in a dry ice bath. The DMS-treated and non-DMS-treated chromatin was 
then eluted from the beads by incubating twice with 250 µl elution buffer (1% SDS, 0.1 
M NaHCO3), shaking at 1000 g for 15 min at 65°C, each time saving the supernatant. 
An aliquot of 200 mM NaCl was added to the eluates and crosslinking was reversed by 
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incubation at 65°C for 5 h. Proteins were digested with 40 µg/ml proteinase K in 10 
mM EDTA and 40 mM Tris pH 6.5 for 1 h at 37°C. Immunoprecipitated DNA was 
purified using a Qiagen kit and eluted with 180 µl ddH2O. To cleave the DMS-treated 
DNA, 20 µl piperidine were added and incubated at 95°C for 30 min. The DNA was 
washed twice by adding 1 ml ddH2O, dried in a Speed Vac and resuspended in 50 µl 
TE. Of the DMS-treated immunoprecipitated DNA, 10% was used for ligation-mediated 
PCR (LMPCR)-assisted in vivo footprinting. An aliquot of the precipitated DNA was 
also analyzed by PCR using primers specific for the murine β-globin downstream 
promoter region (forward primer, 5′-GACAAACATTATTCAGAGGGAGTACCC; 
reverse primer, 5′-AGGTGCACCATGATGTCTGTTTCTGG). 
 
 
4.13.RNA depletion and stable clones production  
 
T98G and U2OS cells were transiently transfected for 24h, 48h and 72h with 
lentiviral pGIPZ shRNA vector encoding a short hairpin RNA against HOXC13 
(NM_017410) (Open Biosystems) by Polyfect tranfection reagent (Qiagen) following 
the manufacturer's instructions. RNA interference control experiments were performed 
using an empty lentiviral pGIPZ vector (Open Biosystems). The HOXC13 
downregulated clone and the control clone were selected using puromycin (3μg/ml) 
after 48h of transient transfection followed by 12 days of selection. 
 
 
4.14.Brdu incorporation experiment 
 
Brdu incorporation experiments were performed on U2OS cells stable transfected 
with shRNA against HOXC13 and with empty lentivar vector (Open Biosystem). 
Asynchronous growing cells were pulsed for 30 h or 1 h with Brdu; the synchronized 
cells were pulsed for 1 h at final concentration of 45 μM. After fixing the cells, they 
were incubated overnight at 4°C and then incubated for 45 minutes at room temperature 
with HCl 3N. After a wash whit 0.1 M Na2B4O7, the BrdU-positive cells were detected 
by using an anti-BrdU antibody (Abcam) incubated for 1h and a secondary rabbit 
antibody Alexa Fluor 488. 
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Cells were stained with propidium iodide 0.02 μg/μl and incubated with RNAse A 
0.5 mg/μl and analyzed by double-flow cytometry analysis on a FACSCalibur (Becton 
Dickinson) instrument, to simultaneously determine the cell cycle profile (DNA 
content) by incorporation of propidium iodide (SIGMA), and the S phase cell 
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